Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Alcohol. 2018 Feb 2;72:33–47. doi: 10.1016/j.alcohol.2018.01.007

CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety

Kristen Elizabeth Pleil 1, Mary Jane Skelly 1
PMCID: PMC6141347  NIHMSID: NIHMS939068  PMID: 30217435

Abstract

Decades of research have described the importance of corticotropin-releasing factor (CRF) signaling in alcohol addiction, as well as in commonly co-expressed neuropsychiatric diseases including anxiety and mood disorders. However, CRF signaling can also acutely regulate binge alcohol consumption, anxiety, and affect in non-dependent animals, possibly via modulation of central monoaminergic signaling. We hypothesize that basal CRF tone is particularly high in animals and humans with an inherent propensity for high anxiety and alcohol consumption, and thus these individuals are at increased risk for the development of alcohol use disorder and comorbid neuropsychiatric diseases. The current review focuses on extrahypothalamic CRF circuits, particularly those stemming from the bed nucleus of the stria terminalis (BNST), found to play a role in basal phenotypes and examines whether the intrinsic hyperactivity of these circuits is sufficient to escalate the expression of these behaviors and steepen the trajectory of development of disease states. We focus our efforts on describing CRF modulation of biogenic amine neuron populations that have widespread projections to the forebrain to modulate behaviors including alcohol and drug intake, stress reactivity, and anxiety. Further, we review the known sex differences and estradiol modulation of these neuron populations and CRF signaling at their synapses to address the question of whether females are more susceptible to the development of comorbid addiction and stress-related neuropsychiatric diseases because of hyperactive extrahypothalamic CRF circuits compared to males.

1) Introduction

Alcohol consumption has profound negative effects across organs in the body that contribute to the incidence of many diseases including cardiovascular disease, hepatic and renal failure, cancers, diabetes, and neuropsychiatric disorders such as addiction and anxiety (Fan, Russell, Stranges, Dorn, & Trevisan, 2008; George, Nutt, Dwyer, & Linnoila, 1990; van de Wiel & de Lange, 2008). The negative impact of alcohol is highly governed by the amount and pattern of its consumption, with repeated cycles of high volume intake to intoxication followed by abstinence-induced withdrawal being the most problematic for both acute and chronic health effects. Recurrent binge drinking and withdrawal have been shown to produce maladaptive plasticity in brain circuits that drive reward-seeking behavior and also to recruit stress circuits, leading to states of anxiety or negative affect that facilitate further alcohol intake (Breese et al., 2005; G. F. Koob, 2003, 2008; Sinha et al., 2008). Because of this close tie between emotional state and alcohol drinking behavior, individuals with an alcohol use disorder are at increased risk for the development of an anxiety or mood disorder, and vice versa. Women are at a particularly high risk for the comorbid expression of these neuropsychiatric diseases (Kessler et al., 1997), suggesting that the neural circuit mechanisms underlying these phenotypes are highly sensitive to the effects of alcohol and stress in females. Therefore, understanding the circuits driving these behaviors in males and females and the plasticity occurring within them that contributes to disease states is critical to understanding the mechanisms of these diseases and to developing successful treatment strategies.

Conceptual models of alcohol and drug abuse posit that early drug seeking behavior is driven by the positive rewarding effects achieved by activation of midbrain dopamine neurons that project to the limbic system, and that plasticity occurs in this circuit across repeated use and withdrawal to decrease DA release and reward. At the same time, because alcohol use is a physiological stressor, neural circuits that underlie the stress response become simultaneously recruited and hyperactivated to produce behavioral states of anxiety and negative affect. Thus even in the absence of the positive reinforcing effects of alcohol, repeated consumption is maintained by the anxiolytic properties of alcohol that provide relief from the sustained negative behavioral state that exists during abstinence (negative reinforcement). Many extrahypothalamic stress circuits have been shown to be involved, including those dense with biogenic amines and “stress” neuropeptides like corticotropin-releasing factor (CRF)(G. Koob & Kreek, 2007b; G. F. Koob, 2004; G. F. Koob & Le Moal, 1997; G. F. Koob, Rassnick, Heinrichs, & Weiss, 1994; G. F. Koob & Volkow, 2016).

CRF is not only critical for the maintenance of neuropsychiatric disease phenotypes but can promote both reward and aversion in naïve animals, including basal binge alcohol drinking and anxiety (Lowery-Gionta et al., 2012; Lowery & Thiele, 2010). CRF-mediated modulation of central monoamine systems may play a role in driving these behavioral phenotypes. For example, recent studies show that CRF neurons in the bed nucleus of the stria terminalis (BNST) within the extended amygdala that project to the midbrain modulate alcohol consumption and anxiety (Pleil, Rinker, et al., 2015; Rinker et al., 2016). CRF signaling modulates the activity of dopamine and norepinephrine neurons to enhance reward and stress reactivity, respectively (Lavicky & Dunn, 1993; Stenzel-Poore, Heinrichs, Rivest, Koob, & Vale, 1994; Wanat, Hopf, Stuber, Phillips, & Bonci, 2008; Weiss et al., 1994), and CRF-mediated activation of serotonergic neurons has been shown to modulate behavioral stress responses (Hammack et al., 2002; Hammack, Schmid, et al., 2003). Interestingly, the BNST projects to the major dopaminergic, serotonergic, and noradrenergic producing nuclei of the brain (Lebow & Chen, 2016); although it is not know whether these all of projections carry CRF, the existence of the pathways raises the intriguing possibility that increased activation of BNST CRF neurons may alter central monoaminergic signaling to drive alcohol drinking and anxiety.

Here, we review and synthesize this emerging literature. We hypothesize that high intrinsic excitability of BNST CRF neurons drives the expression of excessive alcohol consumption and anxiety in non-dependent animals, increasing the likelihood of and leading to earlier and more severe expression of neuropsychiatric disease states, and that differential modulation of central monoaminergic signaling by BNST CRF neurons may facilitate this transition. As women are at increased risk for comorbid alcohol/substance abuse and anxiety disorders (Kessler et al., 1997), we posit that females have upregulated CRF systems compared to males at baseline, conferring vulnerability. We discuss the existing evidence, when available, about known sex differences in and estrogen modulation of limbic CRF circuits and signaling relevant to alcohol drinking and anxiety.

2) CRF regulates alcohol drinking and anxiety

a) CRF is hyperactivated in addiction

CRF is a 41 amino acid neuropeptide with two primary Gs-coupled G protein-coupled receptors, CRFR1 and CRFR2 (Bale & Vale, 2004; Herman et al., 2003). Endogenous levels and polymorphisms in the genes coding for CRF and its receptors are associated with risk for the development of neuropsychiatric diseases including alcohol abuse and anxiety disorders in humans, as well as with many behavioral phenotypes including high stress responsivity and excessive alcohol consumption across mammalian species (Bale & Vale, 2004; Barr et al., 2009; Barr et al., 2008; A. C. Chen et al., 2010; Hayes, Knapp, Breese, & Thiele, 2005; Heilig, 2004; Heilig & Koob, 2007; M. B. Muller et al., 2003; Shekhar, Truitt, Rainnie, & Sajdyk, 2005).

While CRF and its receptors are located throughout the body and modulate stress responsivity in peripheral organs, the primary effects of CRF occur via receptor activation at neural loci (as reviewed in Gilpin, 2012; Lebow & Chen, 2016; Quadros, Macedo, Domingues, & Favoretto, 2016; Valentino & Bangasser, 2016; Valentino, Van Bockstaele, & Bangasser, 2013; Waters et al., 2015). The CRF neuron population in the hypothalamus is known to play a large role in stress responsivity as the initiator of the hypothalamic-pituitary-adrenal (HPA) axis during acute stress responses, but CRF in extrahypothalamic regions can regulate drinking and stress behaviors independent of the HPA axis (Le et al., 2000; Lowery et al., 2010; Pastor et al., 2008). Interestingly, while hypothalamic CRF and HPA axis function is suppressed in neuropsychiatric diseases states including alcohol addiction (Richardson, Lee, O’Dell, Koob, & Rivier, 2008), extrahypothalamic CRF is upregulated. For example, repeated alcohol exposure and withdrawal alter CRF expression within extrahypothalamic regions including the amygdala, prefrontal cortex and BNST, which are key sites for the integration of reward and stress information (Funk, O’Dell, Crawford, & Koob, 2006; Lack, Floyd, & McCool, 2005; Merlo Pich et al., 1995; Olive, Koenig, Nannini, & Hodge, 2002; Sommer et al., 2008; Zorrilla, Valdez, & Weiss, 2001).

Several reviews over the past decade have elegantly described the role of extrahypothalamic CRF signaling in alcohol dependence and addiction (Heilig & Koob, 2007; Lowery & Thiele, 2010; Phillips, Reed, & Pastor, 2015; Zorrilla, Logrip, & Koob, 2014). CRF is recruited during binge alcohol drinking and altered in rodent models of alcohol dependence (Ayanwuyi et al., 2013; Barr et al., 2009; Heilig & Koob, 2007; Kaur, Li, Stenzel-Poore, & Ryabinin, 2012; Lowery-Gionta et al., 2012; Lowery et al., 2010; Lowery & Thiele, 2010; Roberto et al., 2010; Sparta et al., 2008; Valdez & Koob, 2004). Pharmacological manipulations have shown a causal relationship between CRF signaling and behaviors associated with alcohol use disorder, from excessive alcohol consumption and alcohol-induced aggression (Quadros et al., 2014) to withdrawal-induced anxiety, negative affect, and relapse behavior (Baldwin, Rassnick, Rivier, Koob, & Britton, 1991; Breese, Knapp, & Overstreet, 2004; Huang et al., 2010; Le et al., 2000; Rassnick, Heinrichs, Britton, & Koob, 1993; Valdez et al., 2002; Valdez, Zorrilla, Roberts, & Koob, 2003) including stress-induced reinstatement (Funk et al., 2006; Le et al., 2000; Liu & Weiss, 2002). In particular, CRF signaling at CRFR1 and CRFR2 in extrahypothalamic regions in the brain are involved in heavy alcohol drinking during the transition to and maintenance of alcohol dependence (Chu, Koob, Cole, Zorrilla, & Roberts, 2007; Funk & Koob, 2007; Funk, Zorrilla, Lee, Rice, & Koob, 2007; Gehlert et al., 2007; Gilpin, 2012; Hansson et al., 2006; Le et al., 2000; Sommer et al., 2008).

These data suggest that plasticity in CRF signaling is crucial in the development of alcohol use disorder and comorbid anxiety (reviewed in Heilig & Koob, 2007; G. F. Koob, 2008; G. F. Koob & Nestler, 1997; Phillips et al., 2015). Taken together, these and other studies have demonstrated that CRF is recruited across repeated alcohol use and withdrawal and is critical for the maintenance of neuropsychiatric disease phenotypes. This relationship suggests that individuals with elevated basal CRF system reactivity may, upon initiation of alcohol drinking, transition to dependence more quickly. Indeed, evidence suggests that CRF can promote excessive alcohol consumption, anxiety, and aversion in the absence of prior alcohol exposure (discussed in the next section). As females tend to develop alcohol dependence more rapidly than males, we hypothesize that sex-dependent differences in CRF signaling may underlie this relationship.

b) CRF regulates basal reward and anxiety: systemic evidence

The negative health effects of alcohol consumption in humans are thought to result from “binge drinking”, intake marked by high volume alcohol consumption (achieving a blood ethanol concentration (BEC) of at least 80 mg/dl), and subsequent withdrawal. Binge drinking behavior is a major risk factor for alcohol use and anxiety disorders in humans (Blazer & Wu, 2009; Courtney & Polich, 2009; Enoch, 2006) and is modeled well in rodents (Lange & Voas, 2000; Lyons, Lowery, Sparta, & Thiele, 2008; Rhodes, Best, Belknap, Finn, & Crabbe, 2005; Rhodes et al., 2007; Thiele & Navarro, 2013). Initial alcohol/drug use is thought to elicit increases in mid- and hindbrain dopamine, norepinephrine, and opioid signaling that encodes drug reward, followed by withdrawal-induced negative affect and anxiety driven by stress neuropeptides including CRF (J. B. Becker, Perry, & Westenbroek, 2012; Sarnyai, Shaham, & Heinrichs, 2001), which in turn promote intake. While in some brain regions CRF seems to become further and further recruited across repeated consumption (G. F. Koob, 2013, 2014), CRF itself can elicit binge drinking and anxiety in naïve animals.

CRF signaling has been shown to modulate drinking in various animal models of escalated alcohol self-administration, including the well-established “drinking in the dark” (DID) and two-bottle choice paradigms, among others. For example, systemic or central administration of CRF and CRFR1 agonists enhance, and CRFR1 antagonists blunt, binge alcohol consumption without altering low, non-binge levels of alcohol intake (Cippitelli et al., 2012; Funk et al., 2007; Lowery-Gionta et al., 2012; Lowery et al., 2010; Richardson, Zhao, et al., 2008; Sparta et al., 2008; Valdez et al., 2002). Similarly, CRFR1 KO mice consume less of a standard high concentration 20% alcohol solution, but not a low concentration solution, than wild type mice in two-bottle choice (Pastor et al., 2011) and DID paradigms (Kaur et al., 2012). Thus, CRF signaling, particularly at CRFR1, appears to be important for excessive alcohol consumption in both dependent and non-dependent states. In humans, CRFR1 polymorphisms are associated with binge drinking and alcohol intake (A. C. Chen et al., 2010; Treutlein et al., 2006), including the ability of stressful life events to predict heavy alcohol drinking (Blomeyer et al., 2008; Schmid et al., 2010). CRF’s role in alcohol consumption is also mediated by signaling at CRFR2; for example, CRF-deficient mice do not develop a conditioned place preference for alcohol as readily as control mice (Olive et al., 2003), and loss of CRFR2 signaling apparently decreases alcohol’s rewarding properties (Giardino, Cocking, Kaur, Cunningham, & Ryabinin, 2011; Ryabinin et al., 2012). Given the role of the CRF system in both the positive and negative reinforcement of alcohol drinking behavior, high basal CRF signaling may be both more rewarding and more aversive, affording CRF a role in positive and negative reinforcement-driven alcohol consumption even in animals that do not have a history of alcohol exposure.

We hypothesize that elevated basal CRF signaling in addiction susceptible individuals may produce a hyperactive stress response, which in turn stimulates excessive drinking and accelerates the frequency and severity binge drinking episodes, thereby hastening the transition to alcohol dependence. In support of this, a line of rats selectively bred to prefer alcohol, termed “P rats”, exhibit increased basal stress reactivity and alcohol consumption, as well as high basal central CRF signaling, compared to non-preferring (NP) rats; specifically, some strains of P rats display high CRF and CRFR1 expression (Hansson et al., 2006; Zhou, Colombo, Gessa, & Kreek, 2013) and potentiated responses to central CRF administration across brain regions (Ehlers et al., 1992). Conversely, stress reactivity and anxiety are blunted in transgenic mice that do not express CRFR1 receptors (Bale & Vale, 2004; M. B. Muller et al., 2003). In humans, there is some evidence that elevated CRF and CRFR1 levels may contribute to anxiety and affective disorders in clinical populations (Risbrough & Stein, 2006). The anxiogenic effect of central CRFR1 activation has been extensively reviewed (Dautzenberg & Hauger, 2002; Reul & Holsboer, 2002; Shekhar et al., 2005; Zorrilla & Koob, 2004). Interestingly, recent evidence suggests that there are sex differences in CRF receptor activation and adaptation in response to stress (Bangasser et al., 2010); these differences may help explain the increased vulnerability of females to developing stress-related pathology, including comorbid alcohol use and anxiety disorders.

c) Sex differences in addiction: are na ve females in a post-dependent state?

Women are more likely than men to have anxiety and mood disorders, as well as comorbid alcohol/substance abuse disorders (Back, 2011; Breslau, 2001; Conway, 2006; Kessler, Chiu, Demler, Merikangas, & Walters, 2005; Steiner et al., 2005; Wilcox & Yates, 1993). For example, co-expression of severe alcohol use disorder (AUD) and anxiety disorders is almost twice as high in women (61%) as men (36%) (Brady & Randall, 1999; Kessler et al., 1997). Given this staggering statistic, it is unsurprising that women have higher stress levels and are more likely to consume alcohol in response to acute stress (Rice & Stuart, 2010; Timko, Finney, & Moos, 2005). While epidemiological data suggest that men are currently more likely to suffer from alcohol abuse disorder, changing social factors that have led to increased public alcohol consumption in women (Slade et al., 2016). These changes are evidenced by the recent report that alcohol use disorder is already more prevalent in teenaged girls than boys (White et al., 2015), which suggests that this gender gap in adults may reverse within the next 20 years. Females across mammalian species also display higher levels of basal stress reactivity/anxiety and binge alcohol consumption than males, suggesting that even prior to the exposure of acute or chronic stressors the mechanisms driving these phenotypes may be engaged to a greater degree in females compared to males. Similarly to the differences observed P rats compared to NP rats, females may have higher basal CRF signaling in critical neural circuits than males and be more sensitive to the effects of both acute and chronic stressors, including alcohol. Furthermore, there is evidence that estradiol interacts with estrogen receptors to increase transcription of the Crh gene, which encodes CRF protein (X. N. Chen, Zhu, Meng, & Zhou, 2008; Lalmansingh & Uht, 2007). Altogether, this increased stress responsivity may confer an augmented trajectory toward the development of neuropsychiatric disease states, the so-called “telescoping effect”. While this vulnerability for disease is known from epidemiological and other observational data, females have largely been excluded from pre-clinical and clinical studies. As such, understanding the role of central CRF circuits and the mechanisms by which this system is modulated in both males and females is imperative to understanding, preventing, and treating these diseases.

Previous work has suggested that telescoping of addiction in women may be driven by the greater likelihood of females to self-medicate anxiety or negative affect with alcohol or drugs (J. B. Becker et al., 2012). In contrast, men are more likely to use drugs initially to achieve positive rewarding/euphoric effects in the absence of anxiety or negative affect, particularly in young people (Kuntsche & Muller, 2012; S. Muller & Kuntsche, 2011). However, the euphoric effects of many drugs are greater in females than males, even in those not previously exposed. For example, female rats develop a CPP at lower doses of cocaine and morphine than males (Karami & Zarrindast, 2008; Russo, 2003b; Zakharova, Wade, & Izenwasser, 2009), and have a more pronounced reinstatement of extinguished cocaine CPP (Bobzean, 2010) as well as greater locomotor responses to acute cocaine administration (Sircar & Kim, 1999). Estradiol potentiates euphoria felt from stimulant use in cycling women (Justice & de Wit, 1999, 2000). Furthermore, ovariectomy decreases cocaine and amphetamine CPP and sensitization, and replacement of ovarian hormones restores these effects in female rats (Russo, 2003a; Silverman & Koenig, 2007; Sircar & Kim, 1999). These findings demonstrate the role of estradiol in modulating drug reward. Although this relationship has yet to be carefully characterized for alcohol reward, there is some evidence that ovarian hormones increase alcohol reward in female rats (Torres, Walker, Beas, & O’Dell, 2014). Furthermore, estradiol has been shown to increase ethanol consumption by female rats and mice (Ford, Eldridge, & Samson, 2002, 2004; Quirarte et al., 2007; Rajasingh et al., 2007). In addition, central CRF signaling increases grooming in females to a greater extent than males and this effect is potentiated in high estrogen states, suggesting that estrogen facilitates the anxiogenic effects of CRF (Wiersielis et al., 2016). More research is needed to understand the role of estradiol in modulating alcohol reward and to determine whether CRF mediates or potentiates any observed effects of ovarian hormones on binge drinking behavior.

3) Critical extrahypothalamic sites for CRF signaling: BNST projections and monoaminergic targets

a) The Bed Nucleus of the Stria Terminalis (BNST): a critical source of extrahypothalamic CRF neurons

CRF and CRF receptor-containing neurons are highly expressed not only in the hypothalamus to initiate the HPA axis but throughout the mammalian brain including the cortex, extended amygdala, thalamus, cerebellum, midbrain and hindbrain (G. F. Koob, 2013; Swanson, Sawchenko, Rivier, & Vale, 1983). Data over the past two decades has illustrated the important role of CRF neurons and signaling in the central nucleus of the amygdala (CeA) in the extended amygdala in addiction and anxiety disorders (Gilpin, Herman, & Roberto, 2015; Silberman & Winder, 2015), and more recently evidence has characterized a critical role for a dense population of CRF neurons in the BNST in regulating behavioral state and driving intake behavior.

The BNST is a critical hub in the neural circuitry mediating stress and reward (G. F. Koob, 2009; Silberman & Winder, 2013). Seated in the extended amygdala, it receives synaptic input from cortical, limbic, thalamic and hindbrain structures and sends projections to downstream regions responsible for coordinating the behavioral stress response and implicated in drug and alcohol self-administration (H. Dong, Petrovich, & Swanson, 2000; H. W. Dong, Petrovich, & Swanson, 2001; H. W. Dong, Petrovich, Watts, & Swanson, 2001; Georges & Aston-Jones, 2001; Kash, 2012; Kash & Winder, 2006; G. Koob & Kreek, 2007a; G. F. Koob et al., 2004; Myers, Mark Dolgas, Kasckow, Cullinan, & Herman, 2013; Shin, Geerling, & Loewy, 2008). Up to 90% of neurons in the BNST are GABAergic (Cullinan, Herman, & Watson, 1993; Kudo et al., 2014; Le Gal LaSalle, Paxinos, & Ben-Ari, 1978; Marcinkiewcz et al., 2016; Silberman, Matthews, & Winder, 2013) and many co-release one or more neuropeptides and express their receptors, including CRF (Ju & Han, 1989; Poulin, Arbour, Laforest, & Drolet, 2009; Rainnie, 1999; Rainnie et al., 2004; Walter, Mai, Lanta, & Gorcs, 1991). The roles of these various afferents and efferents, as well as neurochemical subtypes within the BNST, in addiction, anxiety, and affect has recently been reviewed (Lebow & Chen, 2016; Vranjkovic, Pina, Kash, & Winder, 2017).

BNST CRF neurons have been shown to play important roles in alcohol/drug-seeking behavior and stress responsivity in models of relapse, such as stress-induced reinstatement for cocaine seeking (Vranjkovic et al., 2017). CRF mRNA is increased during alcohol withdrawal and decreased with subsequent acute alcohol, suggesting dynamic modulation of CRF production in these neurons across phases of alcohol intake (Olive et al., 2002). In addition, BNST CRF neurons drive both binge drinking and anxiety in non-dependent male and female mice (Pleil, Lowery-Gionta, et al., 2015; Rinker et al., 2016). While further evidence specifically for the role of CRF neurons in such phenotypes in non-dependent animals is scarce, the BNST has been shown to be involved in many aspects of alcohol/drug seeking behaviors that CRF mediates. For example, the BNST is activated by alcohol-associated cues (Dayas, Liu, Simms, & Weiss, 2007; Hill, Ryabinin, & Cunningham, 2007) and is involved in the expression of CPP for alcohol and other drugs of abuse (Buffalari & See, 2011; Pina, Young, Ryabinin, & Cunningham, 2015; Rogers, Ghee, & See, 2008; Sartor & Aston-Jones, 2012), suggesting it encodes some aspects of alcohol/drug reward. Together, the BNST as a region, and possibly CRF neurons within this region, may be involved in both the positive and negative reinforcement of alcohol consumption.

CRF neurons in the BNST can serve as interneurons or principle neurons with long range projections (Marcinkiewcz et al., 2016; Silberman et al., 2013); as such, CRF signaling elicited by activation of BNST CRF neurons can occur both within the BNST as well as at synapses of long range projections at other sites. CRF signaling within the BNST facilitates anxiety and aversion (Sahuque et al., 2006), startle behavior (Y. Lee & Davis, 1997), and stress reactivity, including stress-induced reinstatement of drug seeking (Cummings 1988; Dong and Swanson 2006a,b; Erb and Stewart 1999). Thus, it is unsurprising that chronic alcohol exposure increases CRF tone in the BNST (Francesconi et al., 2009; Silberman et al., 2013). These studies indicate a potentially substantive role for CRF signaling from local BNST CRF neurons on alcohol and anxiety-related behaviors. However, these studies have yet to be performed using female subjects. It is possible that females have higher basal alcohol consumption and anxiety and stress reactivity than males due to higher CRF tone from tonic activation of BNST CRF neurons.

Interestingly, while BNST volume is larger in male rats, the density of CRF neurons is greater in females (Fukushima, Furuta, Kimura, Akema, & Funabashi, 2013; Funabashi, Kawaguchi, Furuta, Fukushima, & Kimura, 2004). Characterized projection sites of BNST CRF neurons in male rats and mice include the VTA, lateral hypothalamus, and locus coeruleus, however to our knowledge these have not been investigated in females to the same degree. In humans, structural connectivity between the BNST and connected regions is 76% greater in females than males (Avery et al., 2014), suggesting that there is greater density and/or diversity in synaptic connections within the BNST in women. Together, this higher density of CRF neurons and greater connectivity could have profound effects on the function of BNST CRF neurons and the functional and behavioral consequences of their activation.

A large literature has demonstrated that the BNST regulates many behaviors in a sex-specific manner, including aggression, sociability, reproductive and parental behaviors, and pain (Hagiwara, Funabashi, Akema, & Kimura, 2013; Hagiwara et al., 2009; He, Wu, & Yu, 2014; He, Yu, & Wu, 2013; Klampfl, Brunton, Bayerl, & Bosch, 2014, 2016; Martinez, Levy, & Petrulis, 2013; Martinez & Petrulis, 2011; Trainor, Finy, & Nelson, 2008; Trainor, Greiwe, & Nelson, 2006; Trainor, Lin, Finy, Rowland, & Nelson, 2007). We hypothesize that the organization and function of BNST CRF neurons may be fundamentally different in males and females, particularly as related to the described sex differences in alcohol consumption and anxiety behaviors driven by this circuit. Further, the modulation of BNST CRF circuits by sex hormones may play a large role in these differences, evidence for which is discussed in the succeeding sections.

b) The Locus Coeruleus (LC): a critical locus of CRF signaling

The locus coeruleus (LC) is the major source of central norepinephrine (NE). The LC is activated by stress and is an integral part of the neural stress response system (F. J. Chen & Sara, 2007). Afferents from the LC project diffusely across the brain, and increased noradrenergic signaling has been implicated in many neuropsychiatric disease states including anxiety disorders and addiction (Sara, 2009). CRF signaling likely plays a role in driving LC excitability, as the LC is innervated by CRF-containing fibers originating in the central amygdala and BNST (Sakanaka, Shibasaki, & Lederis, 1987; Swanson et al., 1983; Valentino, Page, Van Bockstaele, & Aston-Jones, 1992) and NE-producing LC afferents express CRFR1 (De Souza, 1987; De Souza et al., 1985; Reyes, Glaser, & Van Bockstaele, 2007; Van Bockstaele, Colago, & Valentino, 1996). In fact, local or i.c.v. CRF administration increases the excitability of LC neurons (Curtis, Lechner, Pavcovich, & Valentino, 1997; Prouty, Waterhouse, & Chandler, 2017; Valentino & Foote, 1987, 1988), and CRF administration promotes NE release in LC efferent terminal regions (Lavicky & Dunn, 1993). Intra-LC CRF administration has long been known to promote anxiety (Stenzel-Poore et al., 1994; Weiss et al., 1994), and stress-induced increases in LC CRF levels may alter LC activation states to drive the behavioral stress response (Curtis, Bello, & Valentino, 2001; Valentino, Foote, & Page, 1993; Valentino, Page, & Curtis, 1991). More recently, McCall and colleagues (2015) demonstrated that activation of CRF inputs to the LC increases tonic firing, and this activity is correlated with increased expression of anxiety-like behaviors in mice (McCall et al., 2015). Given the importance of CRF in driving LC excitability and anxiety, this may be one neural locus where individual differences in CRF responsivity promote increased basal stress responses and alcohol addiction vulnerability.

Disrupted noradrenergic signaling has long been implicated in excessive alcohol intake. Alcohol acutely increases plasma NE in non-dependent humans (Howes & Reid, 1985) and mice (Hawley, Major, Schulman, & Lake, 1981; Kovacs, Soroncz, & Tegyei, 2002), and NE depletion may reduce the rewarding effects of alcohol intake (Ventura, De Carolis, Alcaro, & Puglisi-Allegra, 2006). Interestingly, there is some evidence that alcohol withdrawal increases NE levels (Kovacs et al., 2002), and noradrenergic therapeutics that decrease LC excitability have shown some efficacy in reducing drinking and the negative symptoms of alcohol withdrawal in clinical populations (Muzyk, Fowler, Norwood, & Chilipko, 2011; Simpson et al., 2009) as well as in preclinical models of excessive alcohol drinking (Gilpin & Koob, 2010; Le, Harding, Juzytsch, Funk, & Shaham, 2005; Skelly & Weiner, 2014; B. M. Walker, Rasmussen, Raskind, & Koob, 2008). Dysregulated LC excitability is thought to contribute to the anxiogenic state induced by alcohol withdrawal, and CRF signaling may potentiate this excitability; in fact, protracted involuntary alcohol exposure has been shown to increase anxiety, LC excitability, and the distribution of CRF receptors in LC noradrenergic neurons (Retson, Reyes, & Van Bockstaele, 2015). Together, these findings suggest that activation of CRF inputs to the LC may drive drinking acutely and increase the risk of developing alcohol dependence. As such, individuals that are more sensitive to the excitatory effects of CRF signaling on central noradrenaline levels may be more likely to engage in binge drinking and therefore at greater risk of developing alcohol dependence. Understanding the role of CRF in driving the activity of this region could prove important in preventing the progression of alcohol-related disease states. Several studies have demonstrated that the BNST sends CRF producing afferents to the LC (Curtis, Bello, Connolly, & Valentino, 2002; Van Bockstaele, Bajic, Proudfit, & Valentino, 2001; Van Bockstaele et al., 1996; Van Bockstaele, Colago, & Valentino, 1998; Van Bockstaele, Peoples, & Valentino, 1999). Although CRF-containing projections from the central amygdala (CeA) to the LC have been implicated in driving alcohol drinking and anxiety (Gilpin et al., 2015; Valentino & Van Bockstaele, 2008), BNST CRF inputs to this region have been less well characterized but may also play a critical role in driving alcohol drinking and related anxiety. Evidence suggests potential sex differences in the responsivity of the LC neurons to CRF input, although these effects are independent of estrogen signaling. Specifically, morphological differences in the dendritic structure of LC cells may increase the sensitivity of these cells to CRF input from the BNST and other limbic regions in females (Bangasser, Wiersielis, & Khantsis, 2016). Additionally, stress has been shown to increase the firing rate of LC projections to a greater extent in females, and this effect is mediated by CRF (Curtis, Bethea, & Valentino, 2006b). Females also exhibit increased basal sensitivity to CRF and reduced sensitization of CRF-mediated LC excitability following chronic stress when compared to males (Bangasser, 2010; Curtis, Bethea, & Valentino, 2006a). Similarly, although in males CRFR1s apparently internalize following prolonged activation (Bangasser, 2010; Reyes, Fox, Valentino, & Van Bockstaele, 2006; Reyes, Valentino, & Van Bockstaele, 2008), no such compensatory mechanism exists in females (Bangasser et al., 2010; Bangasser et al., 2013). Chronic exposure to alcohol increased activation of LC neurons and the expression of CRF receptors in this region to a greater extent in females than in males (Retson et al., 2015). Together, these findings suggest that CRF-mediated potentiation of LC excitability may be increased in females compared to males, and support our hypothesis that increased sensitivity of the CRF system augments vulnerability to stress-related disorders and alcohol addiction in a sex-dependent manner.

c) The Ventral Tegmental Area (VTA): a critical locus of CRF signaling

A great deal of research over many decades has demonstrated the importance of the mesolimbic dopamine system in driving reward seeking behaviors, including drug and alcohol consumption (Bromberg-Martin, Matsumoto, & Hikosaka, 2010). The ventral tegmental area (VTA) in particular is an important source of dopaminergic afferents to downstream regions involved in driving behavioral responses to reward and aversion. Interestingly, the dopamine system is also directly activated by stressful stimuli (Horger & Roth, 1996); for example, stress increases the firing rate (Anstrom & Woodward, 2005) and synaptic strength (Saal, Dong, Bonci, & Malenka, 2003) of VTA dopamine neurons. Acute stress exposure also increases DA release in brain regions where VTA afferents terminate, including the striatum, prefrontal cortex, nucleus accumbens and amygdala (Abercrombie, Keefe, DiFrischia, & Zigmond, 1989; Adler et al., 2000; Gao & Wan, 2008; Hauger, Risbrough, Brauns, & Dautzenberg, 2006; Inglis & Moghaddam, 1999; McFarland, Davidge, Lapish, & Kalivas, 2004; Soliman et al., 2008; Tidey & Miczek, 1996; B. Wang, 2005).

CRF modulation of VTA DA neurons may enhance the response of these cells to acute stress exposure. The VTA receives a dense CRF projection from the BNST (Rinker et al., 2016; Rodaros, Caruana, Amir, & Stewart, 2007; Vranjkovic et al., 2017), and stress induces CRF release in the VTA possibly via activation of these afferents. For instance, stress increases DA release in brain regions receiving input from VTA afferents (Wanat, 2008), as does central CRF administration (Lavicky & Dunn, 1993), while CRF receptor antagonists reduce cocaine-induced dopamine release (Lodge & Grace, 2005). Additionally, administration of CRF directly into the VTA increases the activation of VTA DA neurons (Wanat et al., 2008), downstream DA release (Lemos et al., 2012; Wanat, 2008), and the expression of dopamine-dependent behaviors (Kalivas, Duffy, & Latimer, 1987; B. Wang et al., 2005). Stress-induced increases in VTA CRF have been shown to increase DA neuron activity in a similar fashion to drugs of abuse (Holly & Miczek, 2016; Sinha, 2008), and CRF can increase inhibition in VTA DA neurons in a manner similar to that observed following chronic stress or protracted cocaine administration (Beckstead, 2009; Creed et al., 2016).

Numerous preclinical studies have demonstrated that VTA DA signaling contributes to the reinforcing effects of ethanol (Gonzales, Job, & Doyon, 2004). Alcohol directly activates VTA DA neurons (Brodie, Pesold, & Appel, 1999) and cross-sensitization of VTA DA neurons by stressors and alcohol has been reported (Roberts, Lessov, & Phillips, 1995). Inhibition of CRF receptors in the VTA decreases alcohol consumption in a voluntary self-administration model of alcohol consumption (Holly et al., 2016), modulates reinstatement of drug seeking following extinction (Holly et al., 2016; Holly & Miczek, 2016; B. Wang, 2005), and drives stress-induced reinstatement of cocaine self-administration via signaling at DA neuron synapses (Wise & Morales, 2010). CRFergic projections from the BNST to the VTA drive reward-seeking behaviors (Jennings et al., 2013; Pina et al., 2015; Rinker et al., 2016), likely by disinhibiting DA neurons. This DA neuron disinhibition by BNST CRF/GABA neurons may be the mechanism by which this projection contributes to CPP for alcohol (Pina et al., 2015) and facilitation of binge alcohol consumption in non-dependent mice (Rinker et al., 2016). Blocking CRF receptors in the VTA produces the same alcohol consumption phenotype as inhibiting BNST CRF neuron terminals in the VTA (Rinker et al., 2016), and activation of BNST CRF projections to the VTA are involved in binge drinking and stress-induced reinstatement of alcohol intake (Rinker et al., 2016; Vranjkovic, Gasser, Gerndt, Baker, & Mantsch, 2014). After 4 weeks of chronic alcohol exposure, CRFR1 inhibition in the VTA decreased alcohol consumption VTA (Albrechet-Souza et al., 2015; Hwa, Debold, & Miczek, 2013; Sparta et al., 2013). Thus, increased basal excitability of BNST CRF projections to the VTA might confer increased addiction vulnerability in certain populations (for example, in females).

Although sex differences in the responsivity of VTA neurons to CRF input has not been directly studied, many groups have uncovered evidence that estrogen modulates VTA DA neuron activity and the rewarding effects of drugs of abuse. For example, estradiol has been shown to modulate dopamine release in response to ethanol in female rats (Dazzi et al., 2007). In humans, females report that cocaine administration produces a more robust feeling of euphoria while in a high-estrogen state (Evans & Foltin, 2010; Evans, Haney, & Foltin, 2002), and preclinical work has demonstrated that estradiol stimulates dopamine release to a greater extend in females than males (J. Becker & Cha, 1989; Robinson & Becker, 1982). Drug-induced dopamine release is potentiated in females during high estrogen states (Q. D. Walker, Ray, & Kuhn, 2006), and assessment of cocaine-induced VTA DA neuron excitability has been shown to be modulated by naturally fluctuating estrogen levels (Calipari et al., 2017). Furthermore, cocaine self-administration is greater in females when circulating estrogen levels are high (Long, Yang, Faingold, & Steven Evans, 2007). Given the suspected role of CRF projections from the BNST to the VTA in driving alcohol intake and anxiety (Pleil, Lowery-Gionta, et al., 2015; Rinker et al., 2016), future work should directly assess whether estrogen-induced modulation of this input contributes to the known effects of estrogen state on drug intake and related behaviors.

d) The Dorsal Raphe Nucleus (DR): a critical locus of CRF signaling

The dorsal raphe nucleus of the brainstem is the primary source of central serotonin and sends afferents broadly, including to limbic and cortical targets implicated in stress responding, affect regulation, and addiction (Hale, Shekhar, & Lowry, 2012; Maier & Watkins, 2005). The DR is innervated by CRF containing fibers, and CRF release in this region impacts the excitability of DR afferents via actions at postsynaptic CRFR1 and CRFR2 (Austin, Rhodes, & Lewis, 1997; Kirby, Rice, & Valentino, 2000; Ruggiero, Underwood, Rice, Mann, & Arango, 1999; Sakanaka et al., 1987; Swanson et al., 1983). Disrupted DR CRF signaling has been implicated in mood and affective disorders in clinical and pre-clinical research (Gold & Chrousos, 2002; Holsboer, 1999; Nemeroff, 1996; Waselus, Valentino, & Van Bockstaele, 2005); for example, CRF-immunoreactivity is increased in the DR of suicide victims who suffered from depression (Austin, Janosky, & Murphy, 2003). As such, the DR is one region where individual differences in basal CRF signaling in response to alcohol and other stressors may contribute to anxiety and addiction vulnerability.

CRF is released in the DR in response to stress (Hammack et al., 2002; Roche, Commons, Peoples, & Valentino, 2003; Valentino & Commons, 2005) and produces a biphasic effect of DR neuron excitability. Specifically, low doses of CRF inhibit neuronal activity and serotonin levels in downstream targets via CRFR1 receptor activation, while at high doses CRF potentiates DR afferent excitability via activation of CRFR2s, resulting in increased serotonin release at terminal sites (Hammack, Pepin, DesMarteau, Watkins, & Maier, 2003; Hammack, Schmid, et al., 2003; Kirby et al., 2000; Pernar, Curtis, Vale, Rivier, & Valentino, 2004; Price, Curtis, Kirby, Valentino, & Lucki, 1998; Price & Lucki, 2001; Valentino & Commons, 2005). Thus, it seems possible that individual differences in the strength of stress-induced CRF release in the DR could result in divergent behavioral stress responses. Importantly, CRF has been shown to modulate serotonin release at terminals of afferents originating in the DR (Price & Lucki, 2001), although modulation of these effects by circulating sex hormones or other variables has yet to be investigated. The DR also contains a small population of CRF-producing neurons; these cells appear to co-localize with serotonin and project to the extended amygdala, including the central amygdala and BNST (Commons, Connolley, & Valentino, 2003; Valentino, Lucki, & Van Bockstaele, 2010).

CRF signaling in the DR has been implicated in promoting ethanol self-administration. For instance, both systemic and intra-DR infusion of a CRFR1 antagonist have been shown to decrease binge alcohol drinking in mice and rats (Hwa et al., 2013; Hwa et al., 2016). In another study, combined alcohol withdrawal and acute stress exposure prompted increased alcohol self-administration and anxiety in rats, and CRFR1 antagonists infused into the DR prevented the anxiogenic effects of this treatment (although without affecting alcohol intake) (Knapp et al., 2011). As reviewed above, stress increases CRF release in the DR, and the net effect of this increased CRF signaling appears to be CRFR-mediated inhibition of DR serotonin projections. This CRF-induced reduction in serotonin signaling has been suggested to promote the initiation of drinking by increasing impulsivity (Valentino et al., 2010; Virkkunen & Linnoila, 1990). In support of this, decreased serotonin signaling has been reported in animal models of alcohol self-administration, and in alcohol naive rats selectively bred for high ethanol preference (LeMarquand, Pihl, & Benkelfat, 1994; McBride & Li, 1998). Likewise, clinical research suggests that decreased serotonergic signaling increases vulnerability to alcohol dependence in humans (Johnson, 2000; Johnson & Ait-Daoud, 2000; LeMarquand et al., 1994). Although the source of CRF release in the BNST in response to alcohol and other stressors is not known, BNST CRF neurons do project to the DR (Holstege, Meiners, & Tan, 1985; H. S. Lee, Kim, Valentino, & Waterhouse, 2003; Weissbourd et al., 2014); more work is needed to determine whether this projection plays a role in CRF-mediated stress and alcohol responses of DR neurons, whether sex differences exist in the responsivity of this system, and whether such differences might confer increased risk of developing comorbid alcohol use and anxiety disorders in women.

The DR may be one region where sex differences in CRF signaling determine differential responses to stress. Several authors have reported that females exhibit a potentiated stress response to acute administration of a serotonin reuptake inhibitor (SSRI) (Carlsson & Carlsson, 1988; Goel & Bale, 2010; McEuen, Semsar, Lim, & Bale, 2009; Nishizawa et al., 1997), and Howerton and colleagues (2014) hypothesized that sex-dependent CRF modulation of DR serotonergic projections may contribute to this phenotypic difference. Indeed, this group demonstrated that intra-DR infusion of a CRFR1 antagonist blunts HPA axis activation and related anxiety in response to acute stress exposure in male, but not female, mice (Howerton et al., 2014). This finding was linked to decreased CRF receptor-mediated neuronal activation in females (Howerton et al., 2014). Another group demonstrated that CRFR1 and CRFR2 levels were higher in the DR of female adolescent rats as compared to males (Lukkes, Norman, Meda, & Andersen, 2016). To our knowledge, sex differences in the responsivity of DR neurons to CRF input have not been studied directly. Future studies should investigate whether there are sex differences in estrogen-dependent modulation of DR excitability or central serotonin signaling, and whether estrogen might interact with CRF to alter the excitability of DR neurons, thereby contributing to the increased binge drinking and rate of transition to alcohol dependence observed in females.

e) Overview of sex differences in CRF modulation of monoaminergic signaling

As discussed above, there is strong evidence that CRF modulates neuronal excitability in several brain regions implicated in anxiety and alcohol addiction, and that these effects may be sex-dependent (Bangasser et al., 2010; Curtis et al., 2006a; Valentino & Bangasser, 2016; Valentino et al., 2013). Although the neurophysiological mechanisms of these sex-related differences vary, taken together these findings suggest that stress and alcohol increase CRF signaling to a greater effect in females than in males. As CRF hypersecretion contributes to stress-related psychopathologies in humans (Austin et al., 2003; Bremner et al., 1997; De Bellis, Gold, Geracioti, Listwak, & Kling, 1993; Heuser et al., 1998; Nemeroff, 1996; Raadsheer, Hoogendijk, Stam, Tilders, & Swaab, 1994; S. S. Wang, Kamphuis, Huitinga, Zhou, & Swaab, 2008), and individuals afflicted with these disorders are more likely to engage in binge alcohol intake (Keyes, Hatzenbuehler, & Hasin, 2011), this difference in CRF signaling may bias females toward increased alcohol addiction vulnerability. In fact, heightened sensitivity of female brains to CRF signaling has been proposed to contribute to the increased incidence of stress-related psychiatric conditions in females (Bangasser, Eck, Telenson, & Salvatore, 2017). This group recently demonstrated that CRF increases BNST activation in females to a greater extent than males, and that plasma estradiol levels are negatively correlated with CRF-induced activation of this region in females (Salvatore et al., 2017). Given the known role of CRF in driving alcohol drinking (Heilig & Koob, 2007; Logrip, Koob, & Zorrilla, 2011; Quadros et al., 2016), we are extending this hypothesis to propose that sex-dependent differences in stress-related CRF release and subsequent signaling may potentiate binge alcohol drinking and promote alcohol addiction vulnerability in females.

Of note, while some of the sex-dependent differences in CRF signaling reviewed herein are dependent on estrogen signaling, others are independent of estrogen release. For example, the observed increased sensitivity of LC noradrenergic neurons to CRF in females appears to occur via an estrogen-independent Gs-coupled mechanism (Bangasser, 2010; Bangasser, Dong, et al., 2017). Similarly, observed sex differences in CRF sensitivity in the DR appear to be explained by differences in the expression of CRF receptors in this region (Howerton et al., 2014). Conversely, although sex differences in VTA CRF responsivity have not been directly studied, many existing studies have implicated estrogen modulation of activity in this region in drug self-administration, raising the intriguing possibility that cyclic alterations in circulating estrogen levels may also impact the effects of CRF signaling on VTA dopamine neuron activity. Interestingly, two recent studies have demonstrated that estrous cycle-dependent fluctuations in ovarian hormones alter the connectivity of CRF-activated brain regions in response to CRF administration (Salvatore et al., 2017; Wiersielis et al., 2016). Together, these findings suggest that both cyclic and structural differences in CRF sensitivity may predispose females toward increased stress-related behaviors, including increased likelihood of alcohol self-administration.

4) Conclusions

Here, we have synthesized evidence regarding CRF modulation of biogenic amine function related to alcohol consumption and anxiety, and we have described how CRF neurons in the BNST may be the source of CRF signaling at those critical sites. Interestingly, some of the many synaptic inputs into the BNST include those from the LC, VTA, and DR, suggesting at least indirect reciprocal modulation of BNST CRF and these amine projection neurons (Marcinkeiwcz 2016; Meloni 2006). For example, natural rewards and drugs of abuse, including alcohol, increase DA release in the BNST (Carboni 2000; Park 2012 or Park 2013), and the rewarding effects of alcohol and sucrose (as measured by CPP) can be attenuated with antagonism of DA D1 receptors in the BNST (Eiler 2003). VTA (and periaqueductal gray) DA neurons have been shown to synapse directly onto BNST CRF neurons (Meloni 2006), so BNST CRF-VTA DA interactions may be critical for the positive reinforcing effects of alcohol that drive binge drinking and potentiated in females.

While to date these DA inputs are the only known to monosynaptically innervate CRF neurons, future studies may reveal that the many GABA, glutamate, and neuropeptide inputs to the BNST (recently reviewed in Vranjkovic et al., 2017) directly modulate CRF neurons. These studies will be illuminating regarding sex differences in BNST CRF neuron function, as estrogen is known to modulate both glutamatergic and GABAergic synaptic transmission via postsynaptic membrane-bound estrogen receptors in a sex-dependent manner. For example, in the hippocampus, estrogen signaling increases postsynaptic glutamatergic function in both sexes but via different mechanisms (Oberlander & Woolley, 2016; Wong & Moss 1992) and retrogradely suppresses inhibitory synaptic transmission via postsynaptic membrane-bound ERα in females but not males (Huang and Woolley 2012; Rudick Woolley 2001). In addition, estrogen can rapidly potentiate neuronal excitability (Wong & Moss, 1991), perhaps as a consequence of these combined mechanisms. Given the known anxiogenic effects of ERα activation (Borrow and Handa 2017), its high expression in the BNST (Trainor et al., 2007; Laflamme et al., 1998), and evidence that it mediates other rapid behavioral effects of estrogen in the BNST (Trainor et al., 2007; 2008), it could also regulate alcohol drinking and anxiety behaviors via modulation of BNST CRF neuron function. Sex differences in the organization of BNST CRF neuron circuits and estradiol modulation of BNST CRF neurons and the CRF signaling that happens at their target loci could have large-scale implications for the observed sex differences in basal behavioral phenotypes and risk for rapid and severe development of neuropsychiatric disease states. BNST CRF neurons could be the source of high extrahypothalamic CRF tone that predispose females to the co-expression of alcohol use and anxiety disorders.

It is important to note that there are many other brain regions where CRF signaling may potentially modulate alcohol intake in a sex-dependent manner. For example, CRF receptor binding is increased in the cortex and amygdala of female rats (Weathington & Cooke, 2012; Weathington, Hamki, & Cooke, 2014), and sex-dependent differences in the distribution of CRF receptors have been reported in the hippocampus (Williams, Akama, Knudsen, McEwen, & Milner, 2011). In general, CRF has been shown to increase neuronal activation across wide swaths of the hindbrain, limbic system, and neocortex, although sex-dependent effects have not always been considered when investigating these effects (Wiersielis et al., 2016). Additionally, CRF signaling has been proposed to promote binge drinking by altering the excitability of extrahypothalamic regions not discussed in this review, including the central amygdala (Lowery-Gionta et al., 2012; Silberman & Winder, 2015; Vendruscolo et al., 2015) and nucleus accumbens (Knapp et al., 2011), and alcohol-induced alterations in glucocorticoid signaling have been shown to alter extrahypothalamic CRF signaling and promote alcohol intake (Edwards, Little, Richardson, & Vendruscolo, 2015). In addition to CRF, other stress-related hormones may differentially contribute to binge drinking in males and females; for example, intriguing new evidence suggests that sex differences exist in the responsivity of amygdala subnuclei to corticosterone which may promote sex differences in stress-induced alcohol intake (Logrip, Oleata, & Roberto, 2017). Taken together with the studies reviewed elsewhere in this article, these findings highlight the importance of identifying the specific and likely complex mechanisms underlying sexually dimorphic brain responses to stress and alcohol. Such research will assist in the development of new tools to prevent and treat alcohol addiction and related disorders.

Supplementary Material

supplement

Highlights.

  • Women are more susceptible to comorbid expression of alcohol use and anxiety disorders, neuropsychiatric diseases that are associated with CRF signaling.

  • Individuals with inherently high central CRF tone may binge drink more and have higher basal anxiety, contributing to disease risk.

  • The bed nucleus of the stria terminalis (BNST) in the extended amygdala is a dense source of extrahypothalamic CRF neurons known to regulate binge alcohol drinking and anxiety, and to project to sites containing biogenic amine-containing neurons.

  • CRF signaling modulates the function of biogenic amine signaling in a sex-dependent manner.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem. 1989;52(5):1655–1658. doi: 10.1111/j.1471-4159.1989.tb09224.x. [DOI] [PubMed] [Google Scholar]
  2. Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology. 2000;22(5):545–550. doi: 10.1016/S0893-133X(99)00153-0. [DOI] [PubMed] [Google Scholar]
  3. Albrechet-Souza L, Hwa LS, Han X, Zhang EY, DeBold JF, Miczek KA. Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice. Alcohol Clin Exp Res. 2015;39(9):1609–1618. doi: 10.1111/acer.12825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anstrom KK, Woodward DJ. Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology. 2005;30(10):1832–1840. doi: 10.1038/sj.npp.1300730. [DOI] [PubMed] [Google Scholar]
  5. Austin MC, Janosky JE, Murphy HA. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry. 2003;8(3):324–332. doi: 10.1038/sj.mp.4001250. [DOI] [PubMed] [Google Scholar]
  6. Austin MC, Rhodes JL, Lewis DA. Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem. Neuropsychopharmacology. 1997;17(5):326–341. doi: 10.1016/S0893-133X(97)00083-3. [DOI] [PubMed] [Google Scholar]
  7. Avery SN, Clauss JA, Winder DG, Woodward N, Heckers S, Blackford JU. BNST neurocircuitry in humans. Neuroimage. 2014;91:311–323. doi: 10.1016/j.neuroimage.2014.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ayanwuyi LO, Carvajal F, Lerma-Cabrera JM, Domi E, Bjork K, Ubaldi M, … Cippitelli A. Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats. Front Psychiatry. 2013;4:23. doi: 10.3389/fpsyt.2013.00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Back S. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. The American Journal of Drug and Alcohol Abuse. 2011;37 doi: 10.3109/00952990.2011.596982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 1991;103(2):227–232. doi: 10.1007/BF02244208. [DOI] [PubMed] [Google Scholar]
  11. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44:525–557. doi: 10.1146/annurev.pharmtox.44.101802.121410. [DOI] [PubMed] [Google Scholar]
  12. Bangasser DA. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry. 2010;15 doi: 10.1038/mp.2010.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, … Valentino RJ. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry. 2010;15(9):877, 896–904. doi: 10.1038/mp.2010.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bangasser DA, Dong H, Carroll J, Plona Z, Ding H, Rodriguez L, … Valentino RJ. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer’s disease-related signaling. Mol Psychiatry. 2017;22(8):1126–1133. doi: 10.1038/mp.2016.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bangasser DA, Eck SR, Telenson AM, Salvatore M. Sex differences in stress regulation of arousal and cognition. Physiol Behav. 2017 doi: 10.1016/j.physbeh.2017.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bangasser DA, Reyes BA, Piel D, Garachh V, Zhang XY, Plona ZM, … Valentino RJ. Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry. 2013;18(2):166–173. doi: 10.1038/mp.2012.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bangasser DA, Wiersielis KR, Khantsis S. Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress. Brain Res. 2016;1641(Pt B):177–188. doi: 10.1016/j.brainres.2015.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Barr CS, Dvoskin RL, Gupte M, Sommer W, Sun H, Schwandt ML, … Heilig M. Functional CRH variation increases stress-induced alcohol consumption in primates. Proc Natl Acad Sci U S A. 2009;106(34):14593–14598. doi: 10.1073/pnas.0902863106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Barr CS, Dvoskin RL, Yuan Q, Lipsky RH, Gupte M, Hu X, … Goldman D. CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques. Arch Gen Psychiatry. 2008;65(8):934–944. doi: 10.1001/archpsyc.65.8.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Becker J, Cha J. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res. 1989;35 doi: 10.1016/s0166-4328(89)80112-3. [DOI] [PubMed] [Google Scholar]
  21. Becker JB, Perry AN, Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biology of Sex Differences. 2012;3(1):14. doi: 10.1186/2042-6410-3-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Beckstead MJ. CRF Enhancement of GIRK Channel-Mediated Transmission in Dopamine Neurons. 2009;34 doi: 10.1038/npp.2009.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Blazer DG, Wu LT. The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry. 2009;166(10):1162–1169. doi: 10.1176/appi.ajp.2009.09010016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry. 2008;63(2):146–151. doi: 10.1016/j.biopsych.2007.04.026. [DOI] [PubMed] [Google Scholar]
  25. Bobzean SAM. Influence of sex on reinstatement of cocaine-conditioned place preference. Brain Res Bull. 2010;83 doi: 10.1016/j.brainresbull.2010.09.003. [DOI] [PubMed] [Google Scholar]
  26. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am. 1999;22(2):241–252. doi: 10.1016/s0193-953x(05)70074-5. [DOI] [PubMed] [Google Scholar]
  27. Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, … Weiss F. Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res. 2005;29(2):185–195. doi: 10.1097/01.alc.0000153544.83656.3c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Breese GR, Knapp DJ, Overstreet DH. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology. 2004;29(3):470–482. doi: 10.1038/sj.npp.1300282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, … Charney DS. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154(5):624–629. doi: 10.1176/ajp.154.5.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Breslau N. The epidemiology of posttraumatic stress disorder: what is the extent of the problem? J Clin Psychiatry. 2001;62(Suppl 17):16–22. [PubMed] [Google Scholar]
  31. Brodie MS, Pesold C, Appel SB. Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res. 1999;23(11):1848–1852. [PubMed] [Google Scholar]
  32. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010;68 doi: 10.1016/j.neuron.2010.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Buffalari DM, See RE. Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology (Berl) 2011;213(1):19–27. doi: 10.1007/s00213-010-2008-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Calipari ES, Juarez B, Morel C, Walker DM, Cahill ME, Ribeiro E, … Nestler EJ. Dopaminergic dynamics underlying sex-specific cocaine reward. Nat Commun. 2017;8:13877. doi: 10.1038/ncomms13877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Carlsson M, Carlsson A. A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(1):53–61. doi: 10.1016/0278-5846(88)90061-9. [DOI] [PubMed] [Google Scholar]
  36. Chen AC, Manz N, Tang Y, Rangaswamy M, Almasy L, Kuperman S, … Porjesz B. Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. Alcohol Clin Exp Res. 2010;34(6):988–996. doi: 10.1111/j.1530-0277.2010.01173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Chen FJ, Sara SJ. Locus coeruleus activation by foot shock or electrical stimulation inhibits amygdala neurons. Neuroscience. 2007;144(2):472–481. doi: 10.1016/j.neuroscience.2006.09.037. [DOI] [PubMed] [Google Scholar]
  38. Chen XN, Zhu H, Meng QY, Zhou JN. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways. Brain Res. 2008;1223:1–10. doi: 10.1016/j.brainres.2008.05.043. [DOI] [PubMed] [Google Scholar]
  39. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav. 2007;86(4):813–821. doi: 10.1016/j.pbb.2007.03.009. S0091-3057(07)00113-X [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, Heilig M. Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav. 2012;100(3):522–529. doi: 10.1016/j.pbb.2011.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Commons KG, Connolley KR, Valentino RJ. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology. 2003;28(2):206–215. doi: 10.1038/sj.npp.1300045. [DOI] [PubMed] [Google Scholar]
  42. Conway KP. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67 doi: 10.4088/jcp.v67n0211. [DOI] [PubMed] [Google Scholar]
  43. Courtney KE, Polich J. Binge drinking in young adults: Data, definitions, and determinants. Psychol Bull. 2009;135(1):142–156. doi: 10.1037/a0014414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Creed M, Kaufling J, Fois GR, Jalabert M, Yuan T, Luscher C, … Bellone C. Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons via Calcium-Impermeable NMDARs. J Neurosci. 2016;36(42):10759–10768. doi: 10.1523/JNEUROSCI.1703-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Cullinan WE, Herman JP, Watson SJ. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol. 1993;332(1):1–20. doi: 10.1002/cne.903320102. [DOI] [PubMed] [Google Scholar]
  46. Curtis AL, Bello NT, Connolly KR, Valentino RJ. Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J Neuroendocrinol. 2002;14(8):667–682. doi: 10.1046/j.1365-2826.2002.00821.x. [DOI] [PubMed] [Google Scholar]
  47. Curtis AL, Bello NT, Valentino RJ. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J Neurosci. 2001;21(13):RC152. doi: 10.1523/JNEUROSCI.21-13-j0001.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Curtis AL, Bethea T, Valentino RJ. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology. 2006a;31(3):544–554. doi: 10.1038/sj.npp.1300875. [DOI] [PubMed] [Google Scholar]
  49. Curtis AL, Bethea T, Valentino RJ. Sexually Dimorphic Responses of the Brain Norepinephrine System to Stress and Corticotropin-Releasing Factor. Neuropsychopharmacology. 2006b;31 doi: 10.1038/sj.npp.1300875. [DOI] [PubMed] [Google Scholar]
  50. Curtis AL, Lechner SM, Pavcovich LA, Valentino RJ. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther. 1997;281(1):163–172. [PubMed] [Google Scholar]
  51. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 2002;23(2):71–77. doi: 10.1016/s0165-6147(02)01946-6. [DOI] [PubMed] [Google Scholar]
  52. Dayas CV, Liu X, Simms JA, Weiss F. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol Psychiatry. 2007;61(8):979–989. doi: 10.1016/j.biopsych.2006.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Dazzi L, Seu E, Cherchi G, Barbieri PP, Matzeu A, Biggio G. Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat. Neuropsychopharmacology. 2007;32(4):892–901. doi: 10.1038/sj.npp.1301150. [DOI] [PubMed] [Google Scholar]
  54. De Bellis MD, Gold PW, Geracioti TD, Jr, Listwak SJ, Kling MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry. 1993;150(4):656–657. doi: 10.1176/ajp.150.4.656. [DOI] [PubMed] [Google Scholar]
  55. De Souza EB. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci. 1987;7(1):88–100. doi: 10.1523/JNEUROSCI.07-01-00088.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci. 1985;5(12):3189–3203. doi: 10.1523/JNEUROSCI.05-12-03189.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dong H, Petrovich GD, Swanson LW. Organization of projections from the juxtacapsular nucleus of the BST: a PHAL study in the rat. Brain Res. 2000;859(1):1–14. doi: 10.1016/s0006-8993(99)02246-5. [DOI] [PubMed] [Google Scholar]
  58. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev. 2001;38(1–2):192–246. doi: 10.1016/s0165-0173(01)00079-0. [DOI] [PubMed] [Google Scholar]
  59. Dong HW, Petrovich GD, Watts AG, Swanson LW. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol. 2001;436(4):430–455. doi: 10.1002/cne.1079. [DOI] [PubMed] [Google Scholar]
  60. Edwards S, Little HJ, Richardson HN, Vendruscolo LF. Divergent regulation of distinct glucocorticoid systems in alcohol dependence. Alcohol. 2015;49(8):811–816. doi: 10.1016/j.alcohol.2015.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Ehlers CL, Chaplin RI, Wall TL, Lumeng L, Li TK, Owens MJ, Nemeroff CB. Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats. Psychopharmacology (Berl) 1992;106(3):359–364. doi: 10.1007/BF02245418. [DOI] [PubMed] [Google Scholar]
  62. Enoch MA. Genetic and environmental influences on the development of alcoholism: resilience vs. risk. Ann N Y Acad Sci. 2006;1094:193–201. doi: 10.1196/annals.1376.019. [DOI] [PubMed] [Google Scholar]
  63. Evans SM, Foltin RW. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav. 2010;58(1):13–21. doi: 10.1016/j.yhbeh.2009.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Evans SM, Haney M, Foltin RW. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 2002;159(4):397–406. doi: 10.1007/s00213-001-0944-7. [DOI] [PubMed] [Google Scholar]
  65. Fan AZ, Russell M, Stranges S, Dorn J, Trevisan M. Association of lifetime alcohol drinking trajectories with cardiometabolic risk. J Clin Endocrinol Metab. 2008;93(1):154–161. doi: 10.1210/jc.2007-1395. jc.2007-1395 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ford MM, Eldridge JC, Samson HH. Ethanol consumption in the female Long-Evans rat: a modulatory role of estradiol. Alcohol. 2002;26(2):103–113. doi: 10.1016/s0741-8329(01)00203-8. [DOI] [PubMed] [Google Scholar]
  67. Ford MM, Eldridge JC, Samson HH. Determination of an estradiol dose-response relationship in the modulation of ethanol intake. Alcoholism-Clinical and Experimental Research. 2004;28(1):20–28. doi: 10.1097/01.Alc.0000108647.62718.5a. [DOI] [PubMed] [Google Scholar]
  68. Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D, … Sanna PP. Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci. 2009;29(17):5389–5401. doi: 10.1523/JNEUROSCI.5129-08.2009. 29/17/5389 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Fukushima A, Furuta M, Kimura F, Akema T, Funabashi T. Testosterone exposure during the critical period decreases corticotropin-releasing hormone-immunoreactive neurons in the bed nucleus of the stria terminalis of female rats. Neurosci Lett. 2013;534:64–68. doi: 10.1016/j.neulet.2012.11.065. [DOI] [PubMed] [Google Scholar]
  70. Funabashi T, Kawaguchi M, Furuta M, Fukushima A, Kimura F. Exposure to bisphenol A during gestation and lactation causes loss of sex difference in corticotropin-releasing hormone-immunoreactive neurons in the bed nucleus of the stria terminalis of rats. Psychoneuroendocrinology. 2004;29(4):475–485. doi: 10.1016/s0306-4530(03)00055-6. [DOI] [PubMed] [Google Scholar]
  71. Funk CK, Koob GF. A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res. 2007;1155:172–178. doi: 10.1016/j.brainres.2007.04.009. S0006-8993(07)00851-7 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Funk CK, O’Dell LE, Crawford EF, Koob GF. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci. 2006;26(44):11324–11332. doi: 10.1523/JNEUROSCI.3096-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry. 2007;61(1):78–86. doi: 10.1016/j.biopsych.2006.03.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Gao L, Wan X. A novel mechanism linking corticotrophin-releasing factor to ventral tegmental area dopamine neuron firing. J Physiol. 2008;586(17):4037–4038. doi: 10.1113/jphysiol.2008.159079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, … Heilig M. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci. 2007;27(10):2718–2726. doi: 10.1523/JNEUROSCI.4985-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. George DT, Nutt DJ, Dwyer BA, Linnoila M. Alcoholism and panic disorder: is the comorbidity more than coincidence? Acta Psychiatr Scand. 1990;81(2):97–107. doi: 10.1111/j.1600-0447.1990.tb06460.x. [DOI] [PubMed] [Google Scholar]
  77. Georges F, Aston-Jones G. Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci. 2001;21(16):RC160. doi: 10.1523/JNEUROSCI.21-16-j0003.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Giardino WJ, Cocking DL, Kaur S, Cunningham CL, Ryabinin AE. Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS One. 2011;6(10):e26997. doi: 10.1371/journal.pone.0026997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Gilpin NW. Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol. 2012;46(4):329–337. doi: 10.1016/j.alcohol.2011.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Gilpin NW, Herman MA, Roberto M. The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2015;77(10):859–869. doi: 10.1016/j.biopsych.2014.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Gilpin NW, Koob GF. Effects of beta-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology (Berl) 2010;212(3):431–439. doi: 10.1007/s00213-010-1967-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Goel N, Bale TL. Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology. 2010;151(4):1784–1794. doi: 10.1210/en.2009-1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7(3):254–275. doi: 10.1038/sj.mp.4001032. [DOI] [PubMed] [Google Scholar]
  84. Gonzales RA, Job MO, Doyon WM. The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther. 2004;103(2):121–146. doi: 10.1016/j.pharmthera.2004.06.002. [DOI] [PubMed] [Google Scholar]
  85. Hagiwara H, Funabashi T, Akema T, Kimura F. Sex-specific differences in pain response by dopamine in the bed nucleus of the stria terminalis in rats. Neuroreport. 2013;24(4):181–185. doi: 10.1097/WNR.0b013e32835d8540. [DOI] [PubMed] [Google Scholar]
  86. Hagiwara H, Ishida M, Arita J, Mitsushima D, Takahashi T, Kimura F, Funabashi T. The cAMP response element-binding protein in the bed nucleus of the stria terminalis modulates the formalin-induced pain behavior in the female rat. Eur J Neurosci. 2009;30(12):2379–2386. doi: 10.1111/j.1460-9568.2009.07002.x. [DOI] [PubMed] [Google Scholar]
  87. Hale MW, Shekhar A, Lowry CA. Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol. 2012;32(5):695–708. doi: 10.1007/s10571-012-9827-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Hammack SE, Pepin JL, DesMarteau JS, Watkins LR, Maier SF. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav Brain Res. 2003;147(1–2):55–64. doi: 10.1016/s0166-4328(03)00133-5. [DOI] [PubMed] [Google Scholar]
  89. Hammack SE, Richey KJ, Schmid MJ, LoPresti ML, Watkins LR, Maier SF. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J Neurosci. 2002;22(3):1020–1026. doi: 10.1523/JNEUROSCI.22-03-01020.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hammack SE, Schmid MJ, LoPresti ML, Der-Avakian A, Pellymounter MA, Foster AC, … Maier SF. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J Neurosci. 2003;23(3):1019–1025. doi: 10.1523/JNEUROSCI.23-03-01019.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, … Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A. 2006;103(41):15236–15241. doi: 10.1073/pnas.0604419103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets. 2006;5(4):453–479. doi: 10.2174/187152706777950684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Hawley RJ, Major LF, Schulman EA, Lake CR. CSF levels of norepinephrine during alcohol withdrawal. Arch Neurol. 1981;38(5):289–292. doi: 10.1001/archneur.1981.00510050055008. [DOI] [PubMed] [Google Scholar]
  94. Hayes DM, Knapp DJ, Breese GR, Thiele TE. Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res. 2005;29(5):721–729. doi: 10.1097/01.ALC.0000164375.16838.F3. 00000374-200505000-00004 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. He F, Wu R, Yu P. Study of Fos, androgen receptor and testosterone expression in the sub-regions of medial amygdala, bed nucleus of stria terminalis and medial preoptic area in male Mandarin voles in response to chemosensory stimulation. Behav Brain Res. 2014;258:65–74. doi: 10.1016/j.bbr.2013.10.004. [DOI] [PubMed] [Google Scholar]
  96. He F, Yu P, Wu R. Relationship between sexual satiety and motivation, brain androgen receptors and testosterone in male mandarin voles. Behav Brain Res. 2013;250:257–263. doi: 10.1016/j.bbr.2013.05.022. [DOI] [PubMed] [Google Scholar]
  97. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides. 2004;38(4):213–224. doi: 10.1016/j.npep.2004.05.002. [DOI] [PubMed] [Google Scholar]
  98. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007;30(8):399–406. doi: 10.1016/j.tins.2007.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24(3):151–180. doi: 10.1016/j.yfrne.2003.07.001. [DOI] [PubMed] [Google Scholar]
  100. Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, … Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety. 1998;8(2):71–79. [PubMed] [Google Scholar]
  101. Hill KG, Ryabinin AE, Cunningham CL. FOS expression induced by an ethanol-paired conditioned stimulus. Pharmacol Biochem Behav. 2007;87(2):208–221. doi: 10.1016/j.pbb.2007.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Holly EN, Boyson CO, Montagud-Romero S, Stein DJ, Gobrogge KL, DeBold JF, Miczek KA. Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic Corticotropin Releasing Factor in the Anterior and Posterior Ventral Tegmental Area. J Neurosci. 2016;36(14):4093–4105. doi: 10.1523/JNEUROSCI.2232-15.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Holly EN, Miczek KA. Ventral tegmental area dopamine revisited: effects of acute and repeated stress. Psychopharmacology (Berl) 2016;233(2):163–186. doi: 10.1007/s00213-015-4151-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res. 1999;33(3):181–214. doi: 10.1016/s0022-3956(98)90056-5. [DOI] [PubMed] [Google Scholar]
  105. Holstege G, Meiners L, Tan K. Projections of the bed nucleus of the stria terminalis to the mesencephalon, pons, and medulla oblongata in the cat. Exp Brain Res. 1985;58(2):379–391. doi: 10.1007/BF00235319. [DOI] [PubMed] [Google Scholar]
  106. Horger BA, Roth RH. The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol. 1996;10(3–4):395–418. doi: 10.1615/critrevneurobiol.v10.i3-4.60. [DOI] [PubMed] [Google Scholar]
  107. Howerton AR, Roland AV, Fluharty JM, Marshall A, Chen A, Daniels D, … Bale TL. Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity. Biol Psychiatry. 2014;75(11):873–883. doi: 10.1016/j.biopsych.2013.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Howes LG, Reid JL. Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration. Clin Sci (Lond) 1985;69(4):423–428. doi: 10.1042/cs0690423. [DOI] [PubMed] [Google Scholar]
  109. Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, … Breese GR. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J Pharmacol Exp Ther. 2010;332(1):298–307. doi: 10.1124/jpet.109.159186. jpet.109.159186 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Hwa LS, Debold JF, Miczek KA. Alcohol in excess: CRF(1) receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berl) 2013;225(2):313–327. doi: 10.1007/s00213-012-2820-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Hwa LS, Shimamoto A, Kayyali T, Norman KJ, Valentino RJ, DeBold JF, Miczek KA. Dissociation of mu-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice. Addict Biol. 2016;21(1):111–124. doi: 10.1111/adb.12189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Inglis FM, Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem. 1999;72(3):1088–1094. doi: 10.1046/j.1471-4159.1999.0721088.x. [DOI] [PubMed] [Google Scholar]
  113. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, Stuber GD. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496(7444):224–228. doi: 10.1038/nature12041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Johnson BA. Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis. Alcohol Clin Exp Res. 2000;24(10):1597–1601. [PubMed] [Google Scholar]
  115. Johnson BA, Ait-Daoud N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (Berl) 2000;149(4):327–344. doi: 10.1007/s002130000371. [DOI] [PubMed] [Google Scholar]
  116. Ju G, Han ZS. Coexistence of corticotropin releasing factor and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat. Neurosci Lett. 1989;99(3):246–250. doi: 10.1016/0304-3940(89)90454-0. [DOI] [PubMed] [Google Scholar]
  117. Justice AJ, de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 1999;145 doi: 10.1007/s002130051033. [DOI] [PubMed] [Google Scholar]
  118. Justice AJ, de Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology. 2000;71 doi: 10.1159/000054520. [DOI] [PubMed] [Google Scholar]
  119. Kalivas PW, Duffy P, Latimer LG. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987;242(3):757–763. [PubMed] [Google Scholar]
  120. Karami M, Zarrindast MR. Morphine sex-dependently induced place conditioning in adult Wistar rats. Eur J Pharmacol. 2008;582 doi: 10.1016/j.ejphar.2007.12.010. [DOI] [PubMed] [Google Scholar]
  121. Kash TL. The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse. Alcohol. 2012;46(4):303–308. doi: 10.1016/j.alcohol.2011.12.004. S0741-8329(12)00036-5 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Kash TL, Winder DG. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology. 2006;51(5):1013–1022. doi: 10.1016/j.neuropharm.2006.06.011. [DOI] [PubMed] [Google Scholar]
  123. Kaur S, Li J, Stenzel-Poore MP, Ryabinin AE. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol Clin Exp Res. 2012;36(2):369–376. doi: 10.1111/j.1530-0277.2011.01610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627. doi: 10.1001/archpsyc.62.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54(4):313–321. doi: 10.1001/archpsyc.1997.01830160031005. [DOI] [PubMed] [Google Scholar]
  126. Keyes KM, Hatzenbuehler ML, Hasin DS. Stressful life experiences, alcohol consumption, and alcohol use disorders: the epidemiologic evidence for four main types of stressors. Psychopharmacology (Berl) 2011;218(1):1–17. doi: 10.1007/s00213-011-2236-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology. 2000;22(2):148–162. doi: 10.1016/S0893-133X(99)00093-7. [DOI] [PubMed] [Google Scholar]
  128. Klampfl SM, Brunton PJ, Bayerl DS, Bosch OJ. Hypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats. J Neurosci. 2014;34(29):9665–9676. doi: 10.1523/JNEUROSCI.4220-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Klampfl SM, Brunton PJ, Bayerl DS, Bosch OJ. CRF-R1 activation in the anterior-dorsal BNST induces maternal neglect in lactating rats via an HPA axis-independent central mechanism. Psychoneuroendocrinology. 2016;64:89–98. doi: 10.1016/j.psyneuen.2015.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Knapp DJ, Overstreet DH, Huang M, Wills TA, Whitman BA, Angel RA, … Breese GR. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology (Berl) 2011;218(1):179–189. doi: 10.1007/s00213-011-2366-5. [DOI] [PubMed] [Google Scholar]
  131. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007a;164(8):1149–1159. doi: 10.1176/appi.ajp.2007.05030503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007b;164 doi: 10.1176/appi.ajp.2007.05030503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Koob GF. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol. 2003;13(6):442–452. doi: 10.1016/j.euroneuro.2003.08.005. S0924977X03001780 [pii] [DOI] [PubMed] [Google Scholar]
  134. Koob GF. Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience & Biobehavioral Reviews. 2004;27 doi: 10.1016/j.neubiorev.2003.11.007. [DOI] [PubMed] [Google Scholar]
  135. Koob GF. A role for brain stress systems in addiction. Neuron. 2008;59(1):11–34. doi: 10.1016/j.neuron.2008.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Koob GF. Brain stress systems in the amygdala and addiction. Brain Res. 2009;1293:61–75. doi: 10.1016/j.brainres.2009.03.038. S0006-8993(09)00602-7 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr Top Behav Neurosci. 2013;13:3–30. doi: 10.1007/7854_2011_129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Koob GF. Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol. 2014;125:33–54. doi: 10.1016/B978-0-444-62619-6.00003-3. [DOI] [PubMed] [Google Scholar]
  139. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, … Sanna PP. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev. 2004;27(8):739–749. doi: 10.1016/j.neubiorev.2003.11.007. S0149763403001489 [pii] [DOI] [PubMed] [Google Scholar]
  140. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278 doi: 10.1126/science.278.5335.52. [DOI] [PubMed] [Google Scholar]
  141. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci. 1997;9(3):482–497. doi: 10.1176/jnp.9.3.482. [DOI] [PubMed] [Google Scholar]
  142. Koob GF, Rassnick S, Heinrichs S, Weiss F. Alcohol, the reward system and dependence. EXS. 1994;71:103–114. doi: 10.1007/978-3-0348-7330-7_11. [DOI] [PubMed] [Google Scholar]
  143. Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773. doi: 10.1016/S2215-0366(16)00104-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Kovacs GL, Soroncz M, Tegyei I. Plasma catecholamines in ethanol tolerance and withdrawal in mice. Eur J Pharmacol. 2002;448(2–3):151–156. doi: 10.1016/s0014-2999(02)01939-8. [DOI] [PubMed] [Google Scholar]
  145. Kudo T, Konno K, Uchigashima M, Yanagawa Y, Sora I, Minami M, Watanabe M. GABAergic neurons in the ventral tegmental area receive dual GABA/enkephalin-mediated inhibitory inputs from the bed nucleus of the stria terminalis. Eur J Neurosci. 2014;39(11):1796–1809. doi: 10.1111/ejn.12503. [DOI] [PubMed] [Google Scholar]
  146. Kuntsche E, Muller S. Why do young people start drinking? Motives for first-time alcohol consumption and links to risky drinking in early adolescence. Eur Addict Res. 2012;18 doi: 10.1159/000333036. [DOI] [PubMed] [Google Scholar]
  147. Lack AK, Floyd DW, McCool BA. Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol. 2005;36(2):83–90. doi: 10.1016/j.alcohol.2005.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Lalmansingh AS, Uht RM. Estradiol Regulates Corticotropin-Releasing Hormone Gene (crh) Expression in a Rapid and Phasic Manner that Parallels Estrogen Receptor- and - Recruitment to a 3'5'-Cyclic Adenosine 5'-Monophosphate Regulatory Region of the Proximal crh Promoter. Endocrinology. 2007;149 doi: 10.1210/en.2007-0372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Lange JE, Voas RB. Defining binge drinking quantities through resulting BACs. Annu Proc Assoc Adv Automot Med. 2000;44:389–404. [PMC free article] [PubMed] [Google Scholar]
  150. Lavicky J, Dunn AJ. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem. 1993;60(2):602–612. doi: 10.1111/j.1471-4159.1993.tb03191.x. [DOI] [PubMed] [Google Scholar]
  151. Le AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl) 2005;179(2):366–373. doi: 10.1007/s00213-004-2036-y. [DOI] [PubMed] [Google Scholar]
  152. Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 2000;150(3):317–324. doi: 10.1007/s002130000411. [DOI] [PubMed] [Google Scholar]
  153. Le Gal LaSalle G, Paxinos G, Ben-Ari Y. Neurochemical mapping of GABAergic systems in the amygdaloid complex and bed nucleus of the stria terminalis. Brain Res. 1978;155(2):397–403. doi: 10.1016/0006-8993(78)91037-5. [DOI] [PubMed] [Google Scholar]
  154. Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. 2016;21(4):450–463. doi: 10.1038/mp.2016.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Lee HS, Kim MA, Valentino RJ, Waterhouse BD. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res. 2003;963(1–2):57–71. doi: 10.1016/s0006-8993(02)03841-6. [DOI] [PubMed] [Google Scholar]
  156. Lee Y, Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci. 1997;17(16):6434–6446. doi: 10.1523/JNEUROSCI.17-16-06434.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry. 1994;36(6):395–421. doi: 10.1016/0006-3223(94)91215-7. [DOI] [PubMed] [Google Scholar]
  158. Lemos JC, Wanat MJ, Smith JS, Reyes BA, Hollon NG, Van Bockstaele EJ, … Phillips PE. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature. 2012;490(7420):402–406. doi: 10.1038/nature11436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci. 2002;22(18):7856–7861. doi: 10.1523/JNEUROSCI.22-18-07856.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Lodge DJ, Grace AA. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J Pharmacol Exp Ther. 2005;314(1):201–206. doi: 10.1124/jpet.105.084913. [DOI] [PubMed] [Google Scholar]
  161. Logrip ML, Koob GF, Zorrilla EP. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs. 2011;25 doi: 10.2165/11587790-000000000-00000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Logrip ML, Oleata C, Roberto M. Sex differences in responses of the basolateral-central amygdala circuit to alcohol, corticosterone and their interaction. Neuropharmacology. 2017;114:123–134. doi: 10.1016/j.neuropharm.2016.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Long C, Yang L, Faingold CL, Steven Evans M. Excitatory amino acid receptor-mediated responses in periaqueductal gray neurons are increased during ethanol withdrawal. Neuropharmacology. 2007;52(3):802–811. doi: 10.1016/j.neuropharm.2006.09.019. [DOI] [PubMed] [Google Scholar]
  164. Lowery-Gionta EG, Navarro M, Li C, Pleil KE, Rinker JA, Cox BR, … Thiele TE. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci. 2012;32(10):3405–3413. doi: 10.1523/JNEUROSCI.6256-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Lowery EG, Spanos M, Navarro M, Lyons AM, Hodge CW, Thiele TE. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology. 2010;35(6):1241–1252. doi: 10.1038/npp.2009.209. npp2009209 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Lowery EG, Thiele TE. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets. 2010;9(1):77–86. doi: 10.2174/187152710790966605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Lukkes JL, Norman KJ, Meda S, Andersen SL. Sex differences in the ontogeny of CRF receptors during adolescent development in the dorsal raphe nucleus and ventral tegmental area. Synapse. 2016;70(3):125–132. doi: 10.1002/syn.21882. [DOI] [PubMed] [Google Scholar]
  168. Lyons AM, Lowery EG, Sparta DR, Thiele TE. Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res. 2008;32(11):1962–1968. doi: 10.1111/j.1530-0277.2008.00784.x. ACER784 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Maier SF, Watkins LR. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 2005;29(4–5):829–841. doi: 10.1016/j.neubiorev.2005.03.021. [DOI] [PubMed] [Google Scholar]
  170. Marcinkiewcz CA, Mazzone CM, D’Agostino G, Halladay LR, Hardaway JA, DiBerto JF, … Kash TL. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature. 2016;537(7618):97–101. doi: 10.1038/nature19318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Martinez LA, Levy MJ, Petrulis A. Endogenous oxytocin is necessary for preferential Fos expression to male odors in the bed nucleus of the stria terminalis in female Syrian hamsters. Horm Behav. 2013;64(4):653–664. doi: 10.1016/j.yhbeh.2013.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Martinez LA, Petrulis A. The bed nucleus of the stria terminalis is critical for sexual solicitation, but not for opposite-sex odor preference, in female Syrian hamsters. Horm Behav. 2011;60(5):651–659. doi: 10.1016/j.yhbeh.2011.08.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. McBride WJ, Li TK. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol. 1998;12(4):339–369. doi: 10.1615/critrevneurobiol.v12.i4.40. [DOI] [PubMed] [Google Scholar]
  174. McCall JG, Al-Hasani R, Siuda ER, Hong DY, Norris AJ, Ford CP, Bruchas MR. CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety. Neuron. 2015;87(3):605–620. doi: 10.1016/j.neuron.2015.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. McEuen JG, Semsar KA, Lim MA, Bale TL. Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity. Endocrinology. 2009;150(8):3709–3716. doi: 10.1210/en.2008-1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. McFarland K, Davidge SB, Lapish CC, Kalivas PW. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci. 2004;24(7):1551–1560. doi: 10.1523/JNEUROSCI.4177-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 1995;15(8):5439–5447. doi: 10.1523/JNEUROSCI.15-08-05439.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, … Wurst W. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003;6(10):1100–1107. doi: 10.1038/nn1123. [DOI] [PubMed] [Google Scholar]
  179. Muller S, Kuntsche E. Do the drinking motives of adolescents mediate the link between their parents’ drinking habits and their own alcohol use? J Stud Alcohol Drugs. 2011;72 doi: 10.15288/jsad.2011.72.429. [DOI] [PubMed] [Google Scholar]
  180. Muzyk AJ, Fowler JA, Norwood DK, Chilipko A. Role of alpha2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother. 2011;45(5):649–657. doi: 10.1345/aph.1P575. [DOI] [PubMed] [Google Scholar]
  181. Myers B, Mark Dolgas C, Kasckow J, Cullinan WE, Herman JP. Central stress-integrative circuits: forebrain glutamatergic and GABAergic projections to the dorsomedial hypothalamus, medial preoptic area, and bed nucleus of the stria terminalis. Brain Struct Funct. 2013 doi: 10.1007/s00429-013-0566-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry. 1996;1(4):336–342. [PubMed] [Google Scholar]
  183. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, … Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94(10):5308–5313. doi: 10.1073/pnas.94.10.5308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Olive MF, Koenig HN, Nannini MA, Hodge CW. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav. 2002;72(1–2):213–220. doi: 10.1016/s0091-3057(01)00748-1. [DOI] [PubMed] [Google Scholar]
  185. Olive MF, Mehmert KK, Koenig HN, Camarini R, Kim JA, Nannini MA, … Hodge CW. A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (Berl) 2003;165(2):181–187. doi: 10.1007/s00213-002-1248-2. [DOI] [PubMed] [Google Scholar]
  186. Pastor R, McKinnon CS, Scibelli AC, Burkhart-Kasch S, Reed C, Ryabinin AE, … Phillips TJ. Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism. Proc Natl Acad Sci U S A. 2008 doi: 10.1073/pnas.0710181105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Pastor R, Reed C, Burkhart-Kasch S, Li N, Sharpe AL, Coste SC, … Phillips TJ. Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice. Psychopharmacology (Berl) 2011;218(1):169–177. doi: 10.1007/s00213-011-2284-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci. 2004;24(6):1305–1311. doi: 10.1523/JNEUROSCI.2885-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Phillips TJ, Reed C, Pastor R. Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation. Genes Brain Behav. 2015;14(1):98–135. doi: 10.1111/gbb.12189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Pina MM, Young EA, Ryabinin AE, Cunningham CL. The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice. Neuropharmacology. 2015;99:627–638. doi: 10.1016/j.neuropharm.2015.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Pleil KE, Lowery-Gionta EG, Crowley NA, Li C, Marcinkiewcz CA, Rose JH, … Kash TL. Effects of chronic ethanol exposure on neuronal function in the prefrontal cortex and extended amygdala. Neuropharmacology. 2015;99:735–749. doi: 10.1016/j.neuropharm.2015.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, … Kash TL. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci. 2015;18(4):545–552. doi: 10.1038/nn.3972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Poulin JF, Arbour D, Laforest S, Drolet G. Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1356–1365. doi: 10.1016/j.pnpbp.2009.06.021. S0278-5846(09)00211-5 [pii] [DOI] [PubMed] [Google Scholar]
  194. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology. 1998;18(6):492–502. doi: 10.1016/S0893-133X(97)00197-8. [DOI] [PubMed] [Google Scholar]
  195. Price ML, Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci. 2001;21(8):2833–2841. doi: 10.1523/JNEUROSCI.21-08-02833.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Prouty EW, Waterhouse BD, Chandler DJ. Corticotropin releasing factor dose-dependently modulates excitatory synaptic transmission in the noradrenergic nucleus locus coeruleus. Eur J Neurosci. 2017;45(5):712–722. doi: 10.1111/ejn.13501. [DOI] [PubMed] [Google Scholar]
  197. Quadros IM, Hwa LS, Shimamoto A, Carlson J, DeBold JF, Miczek KA. Prevention of alcohol-heightened aggression by CRF-R1 antagonists in mice: critical role for DRN-PFC serotonin pathway. Neuropsychopharmacology. 2014;39(12):2874–2883. doi: 10.1038/npp.2014.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Quadros IM, Macedo GC, Domingues LP, Favoretto CA. An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence. Front Endocrinol (Lausanne) 2016;7:134. doi: 10.3389/fendo.2016.00134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Quirarte GL, Reid LD, de la Teja IS, Reid ML, Sanchez MA, Diaz-Trujillo A, … Prado-Alcala RA. Estradiol valerate and alcohol intake: dose-response assessments. BMC Pharmacol. 2007;7:3. doi: 10.1186/1471-2210-7-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60(4):436–444. doi: 10.1159/000126778. [DOI] [PubMed] [Google Scholar]
  201. Rainnie DG. Neurons of the bed nucleus of the stria terminalis (BNST). Electrophysiological properties and their response to serotonin. Ann N Y Acad Sci. 1999;877:695–699. doi: 10.1111/j.1749-6632.1999.tb09304.x. [DOI] [PubMed] [Google Scholar]
  202. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci. 2004;24(14):3471–3479. doi: 10.1523/JNEUROSCI.5740-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Rajasingh J, Bord E, Qin G, Ii M, Silver M, Hamada H, … Kishore R. Enhanced voluntary alcohol consumption after estrogen supplementation negates estrogen-mediated vascular repair in ovariectomized mice. Endocrinology. 2007;148(8):3618–3624. doi: 10.1210/en.2006-1357. [DOI] [PubMed] [Google Scholar]
  204. Rassnick S, Heinrichs SC, Britton KT, Koob GF. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993;605(1):25–32. doi: 10.1016/0006-8993(93)91352-s. [DOI] [PubMed] [Google Scholar]
  205. Retson TA, Reyes BA, Van Bockstaele EJ. Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2015;56:66–74. doi: 10.1016/j.pnpbp.2014.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2002;2(1):23–33. doi: 10.1016/s1471-4892(01)00117-5. [DOI] [PubMed] [Google Scholar]
  207. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci. 2006;23(11):2991–2998. doi: 10.1111/j.1460-9568.2006.04820.x. [DOI] [PubMed] [Google Scholar]
  208. Reyes BA, Glaser JD, Van Bockstaele EJ. Ultrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleus. Neurosci Lett. 2007;413(3):216–221. doi: 10.1016/j.neulet.2006.11.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Reyes BA, Valentino RJ, Van Bockstaele EJ. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology. 2008;149(1):122–130. doi: 10.1210/en.2007-0705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav. 2005;84(1):53–63. doi: 10.1016/j.physbeh.2004.10.007. S0031-9384(04)00458-5 [pii] [DOI] [PubMed] [Google Scholar]
  211. Rhodes JS, Ford MM, Yu CH, Brown LL, Finn DA, Garland T, Jr, Crabbe JC. Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav. 2007;6(1):1–18. doi: 10.1111/j.1601-183X.2006.00210.x. GBB210 [pii] [DOI] [PubMed] [Google Scholar]
  212. Rice KG, Stuart J. Differentiating adaptive and maladaptive perfectionism on the MMPI-2 and MIPS revised. J Pers Assess. 2010;92(2):158–167. doi: 10.1080/00223890903510407. [DOI] [PubMed] [Google Scholar]
  213. Richardson HN, Lee SY, O’Dell LE, Koob GF, Rivier CL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci. 2008;28(8):1641–1653. doi: 10.1111/j.1460-9568.2008.06455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, … Koob GF. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav. 2008;88(4):497–510. doi: 10.1016/j.pbb.2007.10.008. S0091-3057(07)00321-8 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Rinker JA, Marshall SA, Mazzone CM, Lowery-Gionta EG, Gulati V, Pleil KE, … Thiele TE. Extended Amygdala to Ventral Tegmental Area Corticotropin-Releasing Factor Circuit Controls Binge Ethanol Intake. Biol Psychiatry. 2016 doi: 10.1016/j.biopsych.2016.02.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Risbrough VB, Stein MB. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav. 2006;50(4):550–561. doi: 10.1016/j.yhbeh.2006.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, … Parsons LH. Corticotropin Releasing Factor-Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence. Biol Psychiatry. 2010 doi: 10.1016/j.biopsych.2009.11.007. S0006-3223(09)01328-6 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Roberts AJ, Lessov CN, Phillips TJ. Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther. 1995;275(2):790–797. [PubMed] [Google Scholar]
  219. Robinson TE, Becker JB. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol. 1982;85 doi: 10.1016/0014-2999(82)90478-2. [DOI] [PubMed] [Google Scholar]
  220. Roche M, Commons KG, Peoples A, Valentino RJ. Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci. 2003;23(3):970–977. doi: 10.1523/JNEUROSCI.23-03-00970.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Rodaros D, Caruana DA, Amir S, Stewart J. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience. 2007;150(1):8–13. doi: 10.1016/j.neuroscience.2007.09.043. [DOI] [PubMed] [Google Scholar]
  222. Rogers JL, Ghee S, See RE. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience. 2008;151(2):579–588. doi: 10.1016/j.neuroscience.2007.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience. 1999;91(4):1343–1354. doi: 10.1016/s0306-4522(98)00703-9. [DOI] [PubMed] [Google Scholar]
  224. Russo SJ. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience. 2003a;120 doi: 10.1016/s0306-4522(03)00317-8. [DOI] [PubMed] [Google Scholar]
  225. Russo SJ. Sex differences in the conditioned rewarding effects of cocaine. Brain Res. 2003b;970 doi: 10.1016/s0006-8993(03)02346-1. [DOI] [PubMed] [Google Scholar]
  226. Ryabinin AE, Tsoory MM, Kozicz T, Thiele TE, Neufeld-Cohen A, Chen A, … Kaur S. Urocortins: CRF’s siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol. 2012;46(4):349–357. doi: 10.1016/j.alcohol.2011.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003;37(4):577–582. doi: 10.1016/s0896-6273(03)00021-7. [DOI] [PubMed] [Google Scholar]
  228. Sahuque LL, Kullberg EF, McGeehan AJ, Kinder JR, Hicks MP, Blanton MG, … Olive MF. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 2006;186(1):122–132. doi: 10.1007/s00213-006-0362-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Sakanaka M, Shibasaki T, Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol. 1987;260(2):256–298. doi: 10.1002/cne.902600209. [DOI] [PubMed] [Google Scholar]
  230. Salvatore M, Wiersielis KR, Luz S, Waxler DE, Bhatnagar S, Bangasser DA. Sex differences in circuits activated by corticotropin releasing factor in rats. Horm Behav. 2017;97:145–153. doi: 10.1016/j.yhbeh.2017.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10(3):211–223. doi: 10.1038/nrn2573. [DOI] [PubMed] [Google Scholar]
  232. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev. 2001;53(2):209–243. [PubMed] [Google Scholar]
  233. Sartor GC, Aston-Jones G. Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. Eur J Neurosci. 2012;36(11):3549–3558. doi: 10.1111/j.1460-9568.2012.08277.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Schmid B, Blomeyer D, Treutlein J, Zimmermann US, Buchmann AF, Schmidt MH, … Laucht M. Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. Int J Neuropsychopharmacol. 2010;13(6):703–714. doi: 10.1017/S1461145709990290. [DOI] [PubMed] [Google Scholar]
  235. Shekhar A, Truitt W, Rainnie D, Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress. 2005;8(4):209–219. doi: 10.1080/10253890500504557. [DOI] [PubMed] [Google Scholar]
  236. Shin JW, Geerling JC, Loewy AD. Inputs to the ventrolateral bed nucleus of the stria terminalis. J Comp Neurol. 2008;511(5):628–657. doi: 10.1002/cne.21870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Silberman Y, Matthews RT, Winder DG. A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J Neurosci. 2013;33(3):950–960. doi: 10.1523/JNEUROSCI.2949-12.2013. 33/3/950 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Silberman Y, Winder DG. Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward. Front Psychiatry. 2013;4:42. doi: 10.3389/fpsyt.2013.00042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Silberman Y, Winder DG. Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions. Alcohol. 2015;49(3):179–184. doi: 10.1016/j.alcohol.2015.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Silverman JL, Koenig JI. Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior. Horm Behav. 2007;52 doi: 10.1016/j.yhbeh.2007.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Simpson TL, Saxon AJ, Meredith CW, Malte CA, McBride B, Ferguson LC, … Raskind M. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcohol Clin Exp Res. 2009;33(2):255–263. doi: 10.1111/j.1530-0277.2008.00807.x. [DOI] [PubMed] [Google Scholar]
  242. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008;1141:105–130. doi: 10.1196/annals.1441.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM. Enhanced Negative Emotion and Alcohol Craving, and Altered Physiological Responses Following Stress and Cue Exposure in Alcohol Dependent Individuals. Neuropsychopharmacology. 2008 doi: 10.1038/npp.2008.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Sircar R, Kim D. Female gonadal hormones differentially modulate cocaine-induced behavioral sensitization in Fischer, Lewis and Sprague–Dawley rats. J Pharmacol Exp Ther. 1999;289 [PubMed] [Google Scholar]
  245. Skelly MJ, Weiner JL. Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use. Brain Behav. 2014;4(4):468–483. doi: 10.1002/brb3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Slade T, Chiu WT, Glantz M, Kessler RC, Lago L, Sampson N, … Degenhardt L. A Cross-National Examination of Differences in Classification of Lifetime Alcohol Use Disorder Between DSM-IV and DSM-5: Findings from the World Mental Health Survey. Alcohol Clin Exp Res. 2016;40(8):1728–1736. doi: 10.1111/acer.13134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Soliman A, O’Driscoll GA, Pruessner J, Holahan AL, Boileau I, Gagnon D, Dagher A. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology. 2008;33(8):2033–2041. doi: 10.1038/sj.npp.1301597. [DOI] [PubMed] [Google Scholar]
  248. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig MA. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry. 2008;63(2):139–145. doi: 10.1016/j.biopsych.2007.01.010. [DOI] [PubMed] [Google Scholar]
  249. Sparta DR, Hopf FW, Gibb SL, Cho SL, Stuber GD, Messing RO, … Bonci A. Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res. 2013;37(10):1680–1687. doi: 10.1111/acer.12153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res. 2008;32(2):259–265. doi: 10.1111/j.1530-0277.2007.00575.x. ACER575 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Steiner M, Allgulander C, Ravindran A, Kosar H, Burt T, Austin C. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Hum Psychopharmacol. 2005;20(1):3–13. doi: 10.1002/hup.648. [DOI] [PubMed] [Google Scholar]
  252. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci. 1994;14(5 Pt 1):2579–2584. doi: 10.1523/JNEUROSCI.14-05-02579.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36(3):165–186. doi: 10.1159/000123454. [DOI] [PubMed] [Google Scholar]
  254. Thiele TE, Navarro M. “Drinking in the dark” (DID) procedures: A model of binge-like ethanol drinking in non-dependent mice. Alcohol. 2013 doi: 10.1016/j.alcohol.2013.08.005. S0741-8329(13)00178-X [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Tidey JW, Miczek KA. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 1996;721(1–2):140–149. doi: 10.1016/0006-8993(96)00159-x. [DOI] [PubMed] [Google Scholar]
  256. Timko C, Finney JW, Moos RH. The 8-year course of alcohol abuse: gender differences in social context and coping. Alcohol Clin Exp Res. 2005;29(4):612–621. doi: 10.1097/01.alc.0000158832.07705.22. [DOI] [PubMed] [Google Scholar]
  257. Torres OV, Walker EM, Beas BS, O’Dell LE. Female rats display enhanced rewarding effects of ethanol that are hormone dependent. Alcohol Clin Exp Res. 2014;38(1):108–115. doi: 10.1111/acer.12213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Trainor BC, Finy MS, Nelson RJ. Rapid effects of estradiol on male aggression depend on photoperiod in reproductively non-responsive mice. Horm Behav. 2008;53(1):192–199. doi: 10.1016/j.yhbeh.2007.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Trainor BC, Greiwe KM, Nelson RJ. Individual differences in estrogen receptor alpha in select brain nuclei are associated with individual differences in aggression. Horm Behav. 2006;50(2):338–345. doi: 10.1016/j.yhbeh.2006.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Trainor BC, Lin S, Finy MS, Rowland MR, Nelson RJ. Photoperiod reverses the effects of estrogens on male aggression via genomic and nongenomic pathways. Proc Natl Acad Sci U S A. 2007;104(23):9840–9845. doi: 10.1073/pnas.0701819104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, … Schumann G. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry. 2006;11(6):594–602. doi: 10.1038/sj.mp.4001813. [DOI] [PubMed] [Google Scholar]
  262. Valdez GR, Koob GF. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav. 2004;79(4):671–689. doi: 10.1016/j.pbb.2004.09.020. [DOI] [PubMed] [Google Scholar]
  263. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res. 2002;26(10):1494–1501. doi: 10.1097/01.ALC.0000033120.51856.F0. [DOI] [PubMed] [Google Scholar]
  264. Valdez GR, Zorrilla EP, Roberts AJ, Koob GF. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol. 2003;29(2):55–60. doi: 10.1016/s0741-8329(03)00020-x. [DOI] [PubMed] [Google Scholar]
  265. Valentino RJ, Bangasser DA. Sex-biased cellular signaling: molecular basis for sex differences in neuropsychiatric diseases. Dialogues Clin Neurosci. 2016;18(4):385–393. doi: 10.31887/DCNS.2016.18.4/rvalentino. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Valentino RJ, Commons KG. Peptides that fine-tune the serotonin system. Neuropeptides. 2005;39(1):1–8. doi: 10.1016/j.npep.2004.09.005. [DOI] [PubMed] [Google Scholar]
  267. Valentino RJ, Foote SL. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology. 1987;45(1):28–36. doi: 10.1159/000124700. [DOI] [PubMed] [Google Scholar]
  268. Valentino RJ, Foote SL. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci. 1988;8(3):1016–1025. doi: 10.1523/JNEUROSCI.08-03-01016.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci. 1993;697:173–188. doi: 10.1111/j.1749-6632.1993.tb49931.x. [DOI] [PubMed] [Google Scholar]
  270. Valentino RJ, Lucki I, Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Res. 2010;1314:29–37. doi: 10.1016/j.brainres.2009.09.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  271. Valentino RJ, Page M, Van Bockstaele E, Aston-Jones G. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience. 1992;48(3):689–705. doi: 10.1016/0306-4522(92)90412-u. [DOI] [PubMed] [Google Scholar]
  272. Valentino RJ, Page ME, Curtis AL. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 1991;555(1):25–34. doi: 10.1016/0006-8993(91)90855-p. [DOI] [PubMed] [Google Scholar]
  273. Valentino RJ, Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol. 2008;583 doi: 10.1016/j.ejphar.2007.11.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Valentino RJ, Van Bockstaele E, Bangasser D. Sex-specific cell signaling: the corticotropin-releasing factor receptor model. Trends Pharmacol Sci. 2013;34(8):437–444. doi: 10.1016/j.tips.2013.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav. 2001;73(3):273–283. doi: 10.1016/s0031-9384(01)00448-6. [DOI] [PubMed] [Google Scholar]
  276. Van Bockstaele EJ, Colago EE, Valentino RJ. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol. 1996;364(3):523–534. doi: 10.1002/(SICI)1096-9861(19960115)364:3<523::AID-CNE10>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  277. Van Bockstaele EJ, Colago EE, Valentino RJ. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol. 1998;10(10):743–757. doi: 10.1046/j.1365-2826.1998.00254.x. [DOI] [PubMed] [Google Scholar]
  278. Van Bockstaele EJ, Peoples J, Valentino RJ. A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry. 1999;46(10):1352–1363. doi: 10.1016/s0006-3223(99)00213-9. [DOI] [PubMed] [Google Scholar]
  279. van de Wiel A, de Lange DW. Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks. Neth J Med. 2008;66(11):467–473. [PubMed] [Google Scholar]
  280. Vendruscolo LF, Estey D, Goodell V, Macshane LG, Logrip ML, Schlosburg JE, … Mason BJ. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Invest. 2015;125(8):3193–3197. doi: 10.1172/JCI79828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  281. Ventura R, De Carolis D, Alcaro A, Puglisi-Allegra S. Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex. Neuroreport. 2006;17(17):1813–1817. doi: 10.1097/01.wnr.0000239964.83566.75. [DOI] [PubMed] [Google Scholar]
  282. Virkkunen M, Linnoila M. Serotonin in early onset, male alcoholics with violent behaviour. Ann Med. 1990;22(5):327–331. doi: 10.3109/07853899009147915. [DOI] [PubMed] [Google Scholar]
  283. Vranjkovic O, Gasser PJ, Gerndt CH, Baker DA, Mantsch JR. Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J Neurosci. 2014;34(37):12504–12514. doi: 10.1523/JNEUROSCI.0680-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Vranjkovic O, Pina M, Kash TL, Winder DG. The bed nucleus of the stria terminalis in drug-associated behavior and affect: A circuit-based perspective. Neuropharmacology. 2017;122:100–106. doi: 10.1016/j.neuropharm.2017.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  285. Walker BM, Rasmussen DD, Raskind MA, Koob GF. alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol. 2008;42(2):91–97. doi: 10.1016/j.alcohol.2007.12.002. S0741-8329(08)00015-3 [pii] [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Walker QD, Ray R, Kuhn CM. Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology. 2006;31 doi: 10.1038/sj.npp.1300915. [DOI] [PubMed] [Google Scholar]
  287. Walter A, Mai JK, Lanta L, Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat. 1991;4(4):281–298. doi: 10.1016/0891-0618(91)90019-9. [DOI] [PubMed] [Google Scholar]
  288. Wanat MJ. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol. 2008;586 doi: 10.1113/jphysiol.2007.150078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  289. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol. 2008;586(8):2157–2170. doi: 10.1113/jphysiol.2007.150078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  290. Wang B. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. Journal of Neuroscience. 2005;25 doi: 10.1523/JNEUROSCI.0955-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci. 2005;25(22):5389–5396. doi: 10.1523/JNEUROSCI.0955-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Wang SS, Kamphuis W, Huitinga I, Zhou JN, Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry. 2008;13(8):786–799. 741. doi: 10.1038/mp.2008.38. [DOI] [PubMed] [Google Scholar]
  293. Waselus M, Valentino RJ, Van Bockstaele EJ. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol. 2005;482(2):155–165. doi: 10.1002/cne.20360. [DOI] [PubMed] [Google Scholar]
  294. Waters RP, Rivalan M, Bangasser DA, Deussing JM, Ising M, Wood SK, … Summers CH. Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci Biobehav Rev. 2015;58:63–78. doi: 10.1016/j.neubiorev.2015.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Weathington JM, Cooke BM. Corticotropin-releasing factor receptor binding in the amygdala changes across puberty in a sex-specific manner. Endocrinology. 2012;153(12):5701–5705. doi: 10.1210/en.2012-1815. [DOI] [PubMed] [Google Scholar]
  296. Weathington JM, Hamki A, Cooke BM. Sex- and region-specific pubertal maturation of the corticotropin-releasing factor receptor system in the rat. J Comp Neurol. 2014;522(6):1284–1298. doi: 10.1002/cne.23475. [DOI] [PubMed] [Google Scholar]
  297. Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD, Nemeroff CB. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull. 1994;35(5–6):561–572. doi: 10.1016/0361-9230(94)90170-8. [DOI] [PubMed] [Google Scholar]
  298. Weissbourd B, Ren J, DeLoach KE, Guenthner CJ, Miyamichi K, Luo L. Presynaptic partners of dorsal raphe serotonergic and GABAergic neurons. Neuron. 2014;83(3):645–662. doi: 10.1016/j.neuron.2014.06.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. White A, Castle IJ, Chen CM, Shirley M, Roach D, Hingson R. Converging Patterns of Alcohol Use and Related Outcomes Among Females and Males in the United States, 2002 to 2012. Alcohol Clin Exp Res. 2015;39(9):1712–1726. doi: 10.1111/acer.12815. [DOI] [PubMed] [Google Scholar]
  300. Wiersielis KR, Wicks B, Simko H, Cohen SR, Khantsis S, Baksh N, … Bangasser DA. Sex differences in corticotropin releasing factor-evoked behavior and activated networks. Psychoneuroendocrinology. 2016;73:204–216. doi: 10.1016/j.psyneuen.2016.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Wilcox J, Yates W. Gender and Psychiatric Comorbidity in Substance–Abusing Individuals. The American Journal on Addictions. 1993;2 [Google Scholar]
  302. Williams TJ, Akama KT, Knudsen MG, McEwen BS, Milner TA. Ovarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites. Exp Neurol. 2011;230(2):186–196. doi: 10.1016/j.expneurol.2011.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  303. Wise RA, Morales M. A ventral tegmental CRF-glutamate-dopamine interaction in addiction. Brain Res. 2010;1314 doi: 10.1016/j.brainres.2009.09.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  304. Zakharova E, Wade D, Izenwasser S. Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav. 2009;92 doi: 10.1016/j.pbb.2008.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  305. Zhou Y, Colombo G, Gessa GL, Kreek MJ. Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats. Neurosci Lett. 2013;554:110–114. doi: 10.1016/j.neulet.2013.08.071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  306. Zorrilla EP, Koob GF. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs. 2004;13(7):799–828. doi: 10.1517/13543784.13.7.799. [DOI] [PubMed] [Google Scholar]
  307. Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 2014;35(2):234–244. doi: 10.1016/j.yfrne.2014.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Zorrilla EP, Valdez GR, Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 2001;158(4):374–381. doi: 10.1007/s002130100773. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplement

RESOURCES